                               SEQUENCE LISTING

<110> DANA-FARBER CANCER INSTITUTE, INC.
 
<120> SELECTIVE TARGETING OF UBIQUITIN- AND UBIQUITIN-LIKE 
      E1-ACTIVATING ENZYMES BY STRUCTURALLY-STABILIZED PEPTIDES

<130> 00530-0348WO1

<140>
<141>

<150> 62/835,721
<151> 2019-04-18

<160> 1365  

<170> PatentIn version 3.5

<210> 1
<211> 16
<212> PRT
<213> Schizosaccharomyces pombe

<400> 1
Met Ala Leu Lys Arg Ile Asn Arg Glu Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 2
<211> 20
<212> PRT
<213> Schizosaccharomyces pombe

<400> 2
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 3
<211> 19
<212> PRT
<213> Homo sapiens

<400> 3
Met Ala Asn Ile Ala Val Gln Arg Ile Lys Arg Glu Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 4
<211> 19
<212> PRT
<213> Homo sapiens

<400> 4
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 5
<211> 20
<212> PRT
<213> Homo sapiens

<400> 5
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu Arg Arg Gln Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 6
<211> 19
<212> PRT
<213> Homo sapiens

<400> 6
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Ala Glu Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 7
<211> 23
<212> PRT
<213> Homo sapiens

<400> 7
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Leu Leu Glu 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 8
<211> 23
<212> PRT
<213> Homo sapiens

<400> 8
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Met Leu Glu 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 9
<211> 16
<212> PRT
<213> Homo sapiens

<400> 9
Met Ala Leu Lys Arg Ile Gln Lys Glu Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 10
<211> 16
<212> PRT
<213> Homo sapiens

<400> 10
Met Ala Leu Lys Arg Ile His Lys Glu Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 11
<211> 16
<212> PRT
<213> Homo sapiens

<400> 11
Met Ala Leu Lys Arg Ile Asn Lys Glu Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 12
<211> 16
<212> PRT
<213> Homo sapiens

<400> 12
Met Ala Leu Lys Arg Ile Gln Lys Glu Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 13
<211> 23
<212> PRT
<213> Homo sapiens

<400> 13
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 14
<211> 23
<212> PRT
<213> Homo sapiens

<400> 14
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 15
<211> 23
<212> PRT
<213> Homo sapiens

<400> 15
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 16
<211> 20
<212> PRT
<213> Homo sapiens

<400> 16
Met His Gly Arg Ala Tyr Leu Leu Leu His Arg Asp Phe Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 17
<211> 25
<212> PRT
<213> Homo sapiens

<400> 17
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Met 
1               5                   10                  15      


Lys Glu Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 18
<211> 27
<212> PRT
<213> Homo sapiens

<400> 18
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln Asp Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 19
<211> 18
<212> PRT
<213> Homo sapiens

<400> 19
Met Ala Gly Leu Pro Arg Arg Ile Ile Lys Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 20
<211> 18
<212> PRT
<213> Homo sapiens

<400> 20
Met Ala Glu Leu Pro His Arg Ile Ile Lys Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 21
<211> 17
<212> PRT
<213> Homo sapiens

<400> 21
Met Gln Arg Ala Ser Arg Leu Lys Arg Glu Leu His Met Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 22
<211> 27
<212> PRT
<213> Homo sapiens

<400> 22
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 23
<211> 25
<212> PRT
<213> Homo sapiens

<400> 23
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 24
<211> 26
<212> PRT
<213> Homo sapiens

<400> 24
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys Glu Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 25
<211> 19
<212> PRT
<213> Homo sapiens

<400> 25
Ala Arg Gly Pro Val Gly Lys Arg Leu Gln Gln Glu Leu Met Thr Leu 
1               5                   10                  15      


Met Met Ser 
            


<210> 26
<211> 18
<212> PRT
<213> Homo sapiens

<400> 26
Met Ala Ser Met Gln Lys Arg Leu Gln Lys Glu Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 27
<211> 18
<212> PRT
<213> Homo sapiens

<400> 27
Ala Lys Lys Phe Phe Ser Thr Val Arg Lys Glu Met Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 28
<211> 23
<212> PRT
<213> Homo sapiens

<400> 28
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Ala Gln Glu 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 29
<211> 17
<212> PRT
<213> Homo sapiens

<400> 29
Met Ala Ala Ser Arg Arg Leu Met Lys Glu Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 30
<211> 17
<212> PRT
<213> Homo sapiens

<400> 30
Met Met Ala Ser Met Arg Val Val Lys Glu Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 31
<211> 19
<212> PRT
<213> Homo sapiens

<400> 31
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Leu Ala Glu Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 32
<211> 23
<212> PRT
<213> Homo sapiens

<400> 32
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Met Lys Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 33
<211> 23
<212> PRT
<213> Homo sapiens

<400> 33
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Met Lys Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 34
<211> 21
<212> PRT
<213> Homo sapiens

<400> 34
Met Ser Ser Pro Ser Pro Gly Lys Arg Arg Met Asp Thr Asp Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 35
<211> 16
<212> PRT
<213> Homo sapiens

<400> 35
Arg Arg Val Ser Val Arg Asp Lys Leu Leu Val Lys Glu Val Ala Glu 
1               5                   10                  15      


<210> 36
<211> 16
<212> PRT
<213> Homo sapiens

<400> 36
Lys Lys Ala Ser Ala Ala Gln Leu Arg Ile Gln Lys Asp Ile Asn Glu 
1               5                   10                  15      


<210> 37
<211> 15
<212> PRT
<213> Homo sapiens

<400> 37
Ala Leu Ser Arg Leu Ala Gln Glu Arg Lys Ala Trp Arg Lys Asp 
1               5                   10                  15  


<210> 38
<211> 17
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: 
      UBA6-binding E2 hA peptide"

<400> 38
Met Ala Ala Ser Arg Leu Glu Leu Asn Leu Val Arg Leu Leu Ser Arg 
1               5                   10                  15      


Cys 
    


<210> 39
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 39
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 40
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<400> 40
Xaa Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 41
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 41
Xaa Pro Ser Ser Xaa Ser Arg Gln Xaa Leu Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 42
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 42
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Xaa Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 43
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 43
Xaa Pro Ser Ser Ala Ser Arg Xaa Leu Leu Arg Xaa Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 44
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 44
Xaa Pro Ser Ser Ala Ser Arg Gln Xaa Leu Arg Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 45
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<400> 45
Xaa Pro Ser Ser Ala Ser Arg Gln Leu Xaa Arg Lys Gln Xaa Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 46
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 46
Xaa Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Xaa Gln Leu Lys Xaa 
1               5                   10                  15      


Ile Gln 
        


<210> 47
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> S-pentenyl alanine 

<400> 47
Xaa Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Xaa Gln 
        


<210> 48
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 48
Xaa Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Gln Xaa Lys Glu 
1               5                   10                  15      


Ile Xaa 
        


<210> 49
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 49
Xaa Pro Ser Ser Xaa Ser Arg Gln Leu Leu Arg Xaa Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 50
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 50
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 51
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<400> 51
Xaa Pro Ser Ser Ala Ser Xaa Gln Leu Leu Arg Lys Gln Xaa Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 52
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<400> 52
Xaa Pro Ser Ser Ala Ser Arg Xaa Leu Leu Arg Lys Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 53
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 53
Xaa Pro Ser Ser Ala Ser Arg Gln Xaa Leu Arg Lys Gln Leu Lys Xaa 
1               5                   10                  15      


Ile Gln 
        


<210> 54
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> S-pentenyl alanine 

<400> 54
Xaa Pro Ser Ser Ala Ser Arg Gln Leu Xaa Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Xaa Gln 
        


<210> 55
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 55
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Ala Glu Tyr Lys 
1               5                   10                  


<210> 56
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 56
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 57
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 57
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 58
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 58
Ala Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 59
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 59
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Arg Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 60
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 60
Met Ser Thr Pro Ala Glu Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 61
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 61
Met Ser Thr Pro Ala Arg Glu Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 62
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 62
Met Ser Thr Pro Ala Arg Arg Glu Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 63
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 63
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Glu Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 64
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 64
Xaa Ala Asn Ile Xaa Val Gln Arg Ile Lys Arg Xaa Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 65
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 65
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 66
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 66
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Arg Arg Xaa Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 67
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 67
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 68
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 68
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Leu Leu Xaa 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 69
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 69
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 70
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 70
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 71
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 71
Xaa Xaa Leu Lys Arg Ile His Lys Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 72
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 72
Xaa Xaa Leu Lys Arg Ile Asn Lys Xaa Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 73
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 73
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 74
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 74
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 75
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 75
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 76
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 76
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 77
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 77
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Arg Asp Xaa Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 78
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 78
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Xaa Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 79
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 79
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln Xaa Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 80
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 80
Xaa Ala Gly Xaa Pro Arg Arg Ile Ile Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 81
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 81
Xaa Ala Glu Xaa Pro His Arg Ile Ile Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 82
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 82
Xaa Gln Xaa Ala Ser Arg Leu Lys Arg Xaa Leu His Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 83
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 83
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 84
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 84
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 85
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 85
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys Xaa Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 86
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 86
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Gln Gln Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 87
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 87
Xaa Ala Ser Xaa Gln Lys Arg Leu Gln Lys Xaa Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 88
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<400> 88
Ala Lys Lys Xaa Phe Ser Thr Val Arg Lys Xaa Xaa Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 89
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 89
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Ala Gln Xaa 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 90
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 90
Xaa Ala Xaa Ser Arg Arg Leu Xaa Lys Xaa Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 91
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 91
Xaa Xaa Xaa Ser Xaa Arg Val Val Lys Xaa Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 92
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 92
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Leu Ala Xaa Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 93
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 93
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 94
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 94
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 95
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 95
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Asp Thr Xaa Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 96
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 96
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 97
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 97
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys 
1               5                   10                  


<210> 98
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 98
Xaa Xaa Leu Lys Arg Ile Asn Arg Xaa Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 99
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 99
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Arg Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 100
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 100
Xaa Ala Asn Ile Xaa Val Gln Arg Ile Lys Arg Xaa Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 101
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 101
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 102
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 102
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Arg Arg Xaa Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 103
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 103
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 104
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 104
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Leu Leu Xaa 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 105
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 105
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 106
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 106
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 107
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine or R-octenyl alanine 

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 107
Xaa Xaa Leu Lys Arg Ile His Lys Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 108
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 108
Xaa Xaa Leu Lys Arg Ile Asn Lys Xaa Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 109
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 109
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 110
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 110
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 111
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 111
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 112
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 112
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 113
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 113
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Arg Asp Xaa Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 114
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 114
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Xaa Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 115
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 115
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln Xaa Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 116
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 116
Xaa Ala Gly Xaa Pro Arg Arg Ile Ile Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 117
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 117
Xaa Ala Glu Xaa Pro His Arg Ile Ile Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 118
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 118
Xaa Gln Xaa Ala Ser Arg Leu Lys Arg Xaa Leu His Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 119
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 119
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 120
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 120
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 121
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<400> 121
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys Xaa Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 122
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 122
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Gln Gln Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 123
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 123
Xaa Ala Ser Xaa Gln Lys Arg Leu Gln Lys Xaa Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 124
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<400> 124
Ala Lys Lys Xaa Phe Ser Thr Val Arg Lys Xaa Xaa Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 125
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 125
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Ala Gln Xaa 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 126
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 126
Xaa Ala Xaa Ser Arg Arg Leu Xaa Lys Xaa Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 127
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 127
Xaa Xaa Xaa Ser Xaa Arg Val Val Lys Xaa Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 128
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 128
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Leu Ala Xaa Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 129
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 129
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 130
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 130
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 131
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<400> 131
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Asp Thr Xaa Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 132
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine or R-octenyl alanine 

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 132
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 133
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine or R-octenyl alanine 

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 133
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys 
1               5                   10                  


<210> 134
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 134
Xaa Xaa Leu Lys Arg Ile Asn Arg Xaa Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 135
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine

<400> 135
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Arg Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 136
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 136
Arg Arg Val Ser Val Xaa Asp Lys Leu Leu Val Lys Xaa Val Ala Glu 
1               5                   10                  15      


<210> 137
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 137
Lys Lys Ala Ser Ala Xaa Gln Leu Arg Ile Gln Lys Xaa Ile Asn Glu 
1               5                   10                  15      


<210> 138
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 138
Ala Leu Ser Arg Xaa Ala Gln Glu Arg Lys Ala Xaa Arg Lys Asp 
1               5                   10                  15  


<210> 139
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 139
Xaa Ala Xaa Ser Arg Leu Glu Leu Asn Xaa Val Arg Leu Leu Ser Arg 
1               5                   10                  15      


Cys 
    


<210> 140
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 140
Arg Arg Val Ser Val Xaa Asp Lys Leu Leu Val Lys Xaa Val Ala Glu 
1               5                   10                  15      


<210> 141
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 141
Lys Lys Ala Ser Ala Xaa Gln Leu Arg Ile Gln Lys Xaa Ile Asn Glu 
1               5                   10                  15      


<210> 142
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 142
Ala Leu Ser Arg Xaa Ala Gln Glu Arg Lys Ala Xaa Arg Lys Asp 
1               5                   10                  15  


<210> 143
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 143
Xaa Ala Xaa Ser Arg Leu Glu Leu Asn Xaa Val Arg Leu Leu Ser Arg 
1               5                   10                  15      


Cys 
    


<210> 144
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 144
Met Ala Asn Ile Ala Val Gln Arg Ile Xaa Arg Glu Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 145
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 145
Met Ser Thr Pro Ala Arg Arg Arg Leu Xaa Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 146
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 146
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu Xaa Arg Gln Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 147
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 147
Met Ala Gly Thr Ala Leu Lys Arg Leu Xaa Ala Glu Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 148
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 148
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Xaa Leu Glu 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 149
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 149
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Xaa Leu Glu 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 150
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<400> 150
Met Ala Leu Lys Arg Ile Xaa Lys Glu Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 151
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<400> 151
Met Ala Leu Lys Arg Ile Xaa Lys Glu Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 152
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<400> 152
Met Ala Leu Lys Arg Ile Xaa Lys Glu Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 153
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<400> 153
Met Ala Leu Lys Arg Ile Xaa Lys Glu Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 154
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 154
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Xaa Lys Glu 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 155
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 155
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Xaa Lys Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 156
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 156
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Xaa Lys Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 157
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 157
Met His Gly Arg Ala Tyr Leu Leu Leu His Xaa Asp Phe Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 158
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<400> 158
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Glu Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 159
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 159
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Xaa Gln Asp Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 160
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<400> 160
Met Ala Gly Leu Pro Arg Arg Ile Xaa Lys Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 161
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<400> 161
Met Ala Glu Leu Pro His Arg Ile Xaa Lys Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 162
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<400> 162
Met Gln Arg Ala Ser Arg Leu Xaa Arg Glu Leu His Met Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 163
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 163
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Xaa Glu Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 164
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<400> 164
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Xaa 
1               5                   10                  15      


Glu Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 165
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<400> 165
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Xaa Lys Glu Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 166
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 166
Ala Arg Gly Pro Val Gly Lys Arg Leu Xaa Gln Glu Leu Met Thr Leu 
1               5                   10                  15      


Met Met Ser 
            


<210> 167
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<400> 167
Met Ala Ser Met Gln Lys Arg Leu Xaa Lys Glu Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 168
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<400> 168
Ala Lys Lys Phe Phe Ser Thr Val Xaa Lys Glu Met Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 169
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 169
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Xaa Gln Glu 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 170
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<400> 170
Met Ala Ala Ser Arg Arg Leu Xaa Lys Glu Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 171
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<400> 171
Met Met Ala Ser Met Arg Val Xaa Lys Glu Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 172
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 172
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Xaa Ala Glu Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 173
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 173
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Xaa Lys Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 174
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 174
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Xaa Lys Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 175
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 175
Met Ser Ser Pro Ser Pro Gly Lys Arg Arg Met Xaa Thr Asp Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 176
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 176
Met Ser Thr Pro Ala Arg Arg Arg Leu Xaa Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 177
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 177
Met Ala Gly Thr Ala Leu Lys Arg Leu Xaa Ala Glu Tyr Lys 
1               5                   10                  


<210> 178
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<400> 178
Met Ala Leu Lys Arg Ile Xaa Arg Glu Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 179
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 179
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Xaa Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 180
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 180
Met Ala Asn Ile Ala Val Gln Arg Ile Lys Xaa Glu Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 181
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 181
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Xaa Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 182
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 182
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu Arg Xaa Gln Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 183
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 183
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Xaa Glu Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 184
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 184
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Leu Xaa Glu 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 185
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 185
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Met Xaa Glu 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 186
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<400> 186
Met Ala Leu Lys Arg Ile Gln Xaa Glu Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 187
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<400> 187
Met Ala Leu Lys Arg Ile His Xaa Glu Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 188
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<400> 188
Met Ala Leu Lys Arg Ile Asn Xaa Glu Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 189
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<400> 189
Met Ala Leu Lys Arg Ile Gln Xaa Glu Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 190
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 190
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 191
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 191
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 192
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 192
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 193
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 193
Met His Gly Arg Ala Tyr Leu Leu Leu His Arg Xaa Phe Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 194
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<400> 194
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Met 
1               5                   10                  15      


Xaa Glu Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 195
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (19)..(19)
<223> Non-natural electrophile containing amino acid or absent 

<400> 195
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Xaa Asp Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 196
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 196
Met Ala Gly Leu Pro Arg Arg Ile Ile Xaa Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 197
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 197
Met Ala Glu Leu Pro His Arg Ile Ile Xaa Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 198
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<400> 198
Met Gln Arg Ala Ser Arg Leu Lys Xaa Glu Leu His Met Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 199
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (19)..(19)
<223> Non-natural electrophile containing amino acid or absent 

<400> 199
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Xaa Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 200
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<400> 200
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Xaa Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 201
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 201
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Xaa Glu Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 202
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 202
Ala Arg Gly Pro Val Gly Lys Arg Leu Gln Xaa Glu Leu Met Thr Leu 
1               5                   10                  15      


Met Met Ser 
            


<210> 203
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 203
Met Ala Ser Met Gln Lys Arg Leu Gln Xaa Glu Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 204
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<400> 204
Ala Lys Lys Phe Phe Ser Thr Val Arg Xaa Glu Met Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 205
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 205
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Ala Xaa Glu 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 206
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<400> 206
Met Ala Ala Ser Arg Arg Leu Met Xaa Glu Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 207
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<400> 207
Met Met Ala Ser Met Arg Val Val Xaa Glu Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 208
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 208
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Leu Xaa Glu Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 209
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 209
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Met Xaa Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 210
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 210
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Met Xaa Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 211
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 211
Met Ser Ser Pro Ser Pro Gly Lys Arg Arg Met Asp Xaa Asp Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 212
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 212
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Xaa Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 213
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 213
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Xaa Glu Tyr Lys 
1               5                   10                  


<210> 214
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<400> 214
Met Ala Leu Lys Arg Ile Asn Xaa Glu Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 215
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 215
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Arg Xaa Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 216
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 216
Met Ala Asn Ile Ala Val Gln Arg Ile Lys Arg Glu Phe Xaa Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 217
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 217
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 218
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 218
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu Arg Arg Gln Leu Xaa Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 219
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 219
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Ala Glu Tyr Xaa Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 220
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 220
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Leu Leu Glu 
1               5                   10                  15      


Leu Xaa Gly Leu Gln Glu Glu 
            20              


<210> 221
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 221
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Met Leu Glu 
1               5                   10                  15      


Leu Xaa Ser Leu Gln Glu Glu 
            20              


<210> 222
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 222
Met Ala Leu Lys Arg Ile Gln Lys Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 223
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 223
Met Ala Leu Lys Arg Ile His Lys Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 224
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 224
Met Ala Leu Lys Arg Ile Asn Lys Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 225
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 225
Met Ala Leu Lys Arg Ile Gln Lys Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 226
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 226
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Thr Leu Asp 
            20              


<210> 227
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 227
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 228
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 228
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 229
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 229
Met His Gly Arg Ala Tyr Leu Leu Leu His Arg Asp Phe Cys Xaa Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 230
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 230
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Met 
1               5                   10                  15      


Lys Glu Ala Xaa Glu Leu Lys Asp Pro 
            20                  25  


<210> 231
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 231
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln Asp Tyr Xaa Arg Ile Lys Lys Asp 
            20                  25          


<210> 232
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 232
Met Ala Gly Leu Pro Arg Arg Ile Ile Lys Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 233
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 233
Met Ala Glu Leu Pro His Arg Ile Ile Lys Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 234
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 234
Met Gln Arg Ala Ser Arg Leu Lys Arg Glu Leu Xaa Met Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 235
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 235
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25          


<210> 236
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 236
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25  


<210> 237
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (21)..(21)
<223> Non-natural electrophile containing amino acid or absent 

<400> 237
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys Glu Val Xaa Thr Leu Thr Ala Asp 
            20                  25      


<210> 238
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 238
Ala Arg Gly Pro Val Gly Lys Arg Leu Gln Gln Glu Leu Xaa Thr Leu 
1               5                   10                  15      


Met Met Ser 
            


<210> 239
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 239
Met Ala Ser Met Gln Lys Arg Leu Gln Lys Glu Leu Xaa Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 240
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 240
Ala Lys Lys Phe Phe Ser Thr Val Arg Lys Glu Met Xaa Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 241
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 241
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Ala Gln Glu 
1               5                   10                  15      


Ala Xaa Thr Leu Ser Thr Ser 
            20              


<210> 242
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 242
Met Ala Ala Ser Arg Arg Leu Met Lys Glu Leu Xaa Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 243
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 243
Met Met Ala Ser Met Arg Val Val Lys Glu Leu Xaa Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 244
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 244
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Leu Ala Glu Phe Xaa Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 245
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 245
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Met Lys Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 246
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 246
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Met Lys Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 247
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<400> 247
Met Ser Ser Pro Ser Pro Gly Lys Arg Arg Met Asp Thr Asp Val Xaa 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 248
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 248
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 249
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 249
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Ala Glu Tyr Xaa 
1               5                   10                  


<210> 250
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 250
Met Ala Leu Lys Arg Ile Asn Arg Glu Leu Xaa Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 251
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 251
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Arg Lys Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 252
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl 

<400> 252
Met Ala Asn Ile Ala Val Gln Arg Ile Xaa Arg Glu Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 253
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 253
Met Ser Thr Pro Ala Arg Arg Arg Leu Xaa Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 254
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 254
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu Xaa Arg Gln Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 255
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 255
Met Ala Gly Thr Ala Leu Lys Arg Leu Xaa Ala Glu Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 256
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 256
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Xaa Leu Glu 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 257
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 257
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Xaa Leu Glu 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 258
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 258
Met Ala Leu Lys Arg Ile Xaa Lys Glu Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 259
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 259
Met Ala Leu Lys Arg Ile Xaa Lys Glu Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 260
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 260
Met Ala Leu Lys Arg Ile Xaa Lys Glu Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 261
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 261
Met Ala Leu Lys Arg Ile Xaa Lys Glu Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 262
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 262
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Xaa Lys Glu 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 263
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 263
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Xaa Lys Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 264
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 264
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Xaa Lys Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 265
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 265
Met His Gly Arg Ala Tyr Leu Leu Leu His Xaa Asp Phe Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 266
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (16)..(16)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 266
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Glu Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 267
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 267
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Xaa Gln Asp Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 268
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 268
Met Ala Gly Leu Pro Arg Arg Ile Xaa Lys Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 269
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 269
Met Ala Glu Leu Pro His Arg Ile Xaa Lys Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 270
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 270
Met Gln Arg Ala Ser Arg Leu Xaa Arg Glu Leu His Met Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 271
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 271
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Xaa Glu Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 272
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (16)..(16)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 272
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Xaa 
1               5                   10                  15      


Glu Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 273
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (17)..(17)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 273
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Xaa Lys Glu Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 274
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 274
Ala Arg Gly Pro Val Gly Lys Arg Leu Xaa Gln Glu Leu Met Thr Leu 
1               5                   10                  15      


Met Met Ser 
            


<210> 275
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 275
Met Ala Ser Met Gln Lys Arg Leu Xaa Lys Glu Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 276
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 276
Ala Lys Lys Phe Phe Ser Thr Val Xaa Lys Glu Met Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 277
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 277
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Xaa Gln Glu 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 278
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 278
Met Ala Ala Ser Arg Arg Leu Xaa Lys Glu Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 279
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 279
Met Met Ala Ser Met Arg Val Xaa Lys Glu Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 280
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 280
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Xaa Ala Glu Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 281
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 281
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Xaa Lys Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 282
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 282
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Xaa Lys Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 283
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 283
Met Ser Ser Pro Ser Pro Gly Lys Arg Arg Met Xaa Thr Asp Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 284
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 284
Met Ser Thr Pro Ala Arg Arg Arg Leu Xaa Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 285
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 285
Met Ala Gly Thr Ala Leu Lys Arg Leu Xaa Ala Glu Tyr Lys 
1               5                   10                  


<210> 286
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 286
Met Ala Leu Lys Arg Ile Xaa Arg Glu Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 287
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 287
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Xaa Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 288
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 288
Met Ala Asn Ile Ala Val Gln Arg Ile Lys Xaa Glu Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 289
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 289
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Xaa Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 290
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 290
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu Arg Xaa Gln Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 291
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 291
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Xaa Glu Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 292
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 292
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Leu Xaa Glu 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 293
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 293
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Met Xaa Glu 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 294
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 294
Met Ala Leu Lys Arg Ile Gln Xaa Glu Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 295
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 295
Met Ala Leu Lys Arg Ile His Xaa Glu Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 296
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 296
Met Ala Leu Lys Arg Ile Asn Xaa Glu Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 297
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 297
Met Ala Leu Lys Arg Ile Gln Xaa Glu Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 298
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 298
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 299
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 299
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 300
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 300
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 301
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 301
Met His Gly Arg Ala Tyr Leu Leu Leu His Arg Xaa Phe Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 302
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (17)..(17)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 302
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Met 
1               5                   10                  15      


Xaa Glu Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 303
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (19)..(19)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 303
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Xaa Asp Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 304
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 304
Met Ala Gly Leu Pro Arg Arg Ile Ile Xaa Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 305
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 305
Met Ala Glu Leu Pro His Arg Ile Ile Xaa Glu Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 306
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 306
Met Gln Arg Ala Ser Arg Leu Lys Xaa Glu Leu His Met Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 307
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (19)..(19)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 307
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Xaa Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 308
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (17)..(17)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 308
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Xaa Glu Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 309
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 309
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Xaa Glu Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 310
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 310
Ala Arg Gly Pro Val Gly Lys Arg Leu Gln Xaa Glu Leu Met Thr Leu 
1               5                   10                  15      


Met Met Ser 
            


<210> 311
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 311
Met Ala Ser Met Gln Lys Arg Leu Gln Xaa Glu Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 312
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 312
Ala Lys Lys Phe Phe Ser Thr Val Arg Xaa Glu Met Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 313
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 313
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Ala Xaa Glu 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 314
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 314
Met Ala Ala Ser Arg Arg Leu Met Xaa Glu Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 315
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 315
Met Met Ala Ser Met Arg Val Val Xaa Glu Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 316
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 316
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Leu Xaa Glu Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 317
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 317
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Met Xaa Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 318
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 318
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Met Xaa Glu 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 319
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 319
Met Ser Ser Pro Ser Pro Gly Lys Arg Arg Met Asp Xaa Asp Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 320
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 320
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Xaa Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 321
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 321
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Xaa Glu Tyr Lys 
1               5                   10                  


<210> 322
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 322
Met Ala Leu Lys Arg Ile Asn Xaa Glu Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 323
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 323
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Arg Xaa Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 324
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 324
Met Ala Asn Ile Ala Val Gln Arg Ile Lys Arg Glu Phe Xaa Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 325
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 325
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 326
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 326
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu Arg Arg Gln Leu Xaa Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 327
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 327
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Ala Glu Tyr Xaa Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 328
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 328
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Leu Leu Glu 
1               5                   10                  15      


Leu Xaa Gly Leu Gln Glu Glu 
            20              


<210> 329
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 329
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Met Leu Glu 
1               5                   10                  15      


Leu Xaa Ser Leu Gln Glu Glu 
            20              


<210> 330
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 330
Met Ala Leu Lys Arg Ile Gln Lys Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 331
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 331
Met Ala Leu Lys Arg Ile His Lys Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 332
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 332
Met Ala Leu Lys Arg Ile Asn Lys Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 333
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 333
Met Ala Leu Lys Arg Ile Gln Lys Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 334
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 334
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Thr Leu Asp 
            20              


<210> 335
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 335
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 336
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 336
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 337
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 337
Met His Gly Arg Ala Tyr Leu Leu Leu His Arg Asp Phe Cys Xaa Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 338
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (20)..(20)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 338
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Met 
1               5                   10                  15      


Lys Glu Ala Xaa Glu Leu Lys Asp Pro 
            20                  25  


<210> 339
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (22)..(22)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 339
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln Asp Tyr Xaa Arg Ile Lys Lys Asp 
            20                  25          


<210> 340
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 340
Met Ala Gly Leu Pro Arg Arg Ile Ile Lys Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 341
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 341
Met Ala Glu Leu Pro His Arg Ile Ile Lys Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 342
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 342
Met Gln Arg Ala Ser Arg Leu Lys Arg Glu Leu Xaa Met Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 343
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (22)..(22)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 343
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25          


<210> 344
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (20)..(20)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 344
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25  


<210> 345
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (21)..(21)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 345
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys Glu Val Xaa Thr Leu Thr Ala Asp 
            20                  25      


<210> 346
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 346
Ala Arg Gly Pro Val Gly Lys Arg Leu Gln Gln Glu Leu Xaa Thr Leu 
1               5                   10                  15      


Met Met Ser 
            


<210> 347
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 347
Met Ala Ser Met Gln Lys Arg Leu Gln Lys Glu Leu Xaa Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 348
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 348
Ala Lys Lys Phe Phe Ser Thr Val Arg Lys Glu Met Xaa Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 349
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 349
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Ala Gln Glu 
1               5                   10                  15      


Ala Xaa Thr Leu Ser Thr Ser 
            20              


<210> 350
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 350
Met Ala Ala Ser Arg Arg Leu Met Lys Glu Leu Xaa Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 351
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 351
Met Met Ala Ser Met Arg Val Val Lys Glu Leu Xaa Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 352
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 352
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Leu Ala Glu Phe Xaa Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 353
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 353
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Met Lys Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 354
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 354
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Met Lys Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 355
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (16)..(16)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 355
Met Ser Ser Pro Ser Pro Gly Lys Arg Arg Met Asp Thr Asp Val Xaa 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 356
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 356
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 357
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 357
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Ala Glu Tyr Xaa 
1               5                   10                  


<210> 358
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 358
Met Ala Leu Lys Arg Ile Asn Arg Glu Leu Xaa Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 359
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 359
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Arg Lys Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 360
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 360
Xaa Ala Asn Ile Ala Xaa Val Gln Arg Ile Xaa Arg Xaa Phe Lys Glu 
1               5                   10                  15      


Val Leu Lys Ser 
            20  


<210> 361
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 361
Xaa Ser Thr Pro Ala Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg 
1               5                   10                  15      


Leu Gln Glu Asp 
            20  


<210> 362
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 362
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Xaa Arg Xaa Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 363
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 363
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 364
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 364
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 365
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 365
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 366
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 366
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 367
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 367
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 368
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 368
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 369
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 369
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 370
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 370
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 371
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 371
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 372
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 372
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 373
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 373
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Xaa Asp Xaa Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 374
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 374
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Xaa Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 375
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 375
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Xaa Gln Xaa Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 376
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 376
Xaa Ala Gly Xaa Pro Arg Arg Ile Xaa Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 377
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 377
Xaa Ala Glu Xaa Pro His Arg Ile Xaa Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 378
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 378
Xaa Gln Xaa Ala Ser Arg Leu Xaa Arg Xaa Leu His Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 379
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 379
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Xaa Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 380
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 380
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Xaa 
1               5                   10                  15      


Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 381
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 381
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Xaa Lys Xaa Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 382
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 382
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Xaa Gln Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 383
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 383
Xaa Ala Ser Xaa Gln Lys Arg Leu Xaa Lys Xaa Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 384
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<400> 384
Ala Lys Lys Xaa Phe Ser Thr Val Xaa Lys Xaa Xaa Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 385
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 385
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Xaa Gln Xaa 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 386
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 386
Xaa Ala Xaa Ser Arg Arg Leu Xaa Lys Xaa Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 387
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 387
Xaa Xaa Xaa Ser Xaa Arg Val Xaa Lys Xaa Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 388
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 388
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Xaa Ala Xaa Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 389
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 389
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 390
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 390
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 391
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 391
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Xaa Thr Xaa Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 392
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 392
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 393
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 393
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys 
1               5                   10                  


<210> 394
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 394
Xaa Xaa Leu Lys Arg Ile Xaa Arg Xaa Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 395
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 395
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Xaa Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 396
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 396
Xaa Ala Asn Ile Xaa Val Gln Arg Ile Lys Xaa Xaa Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 397
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 397
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Xaa Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 398
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 398
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Arg Xaa Xaa Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 399
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 399
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Xaa Xaa Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 400
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 400
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Leu Xaa Xaa 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 401
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 401
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 402
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 402
Xaa Xaa Leu Lys Arg Ile Gln Xaa Xaa Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 403
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 403
Xaa Xaa Leu Lys Arg Ile His Xaa Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 404
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 404
Xaa Xaa Leu Lys Arg Ile Asn Xaa Xaa Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 405
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 405
Xaa Xaa Leu Lys Arg Ile Gln Xaa Xaa Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 406
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 406
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 407
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 407
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 408
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 408
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 409
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 409
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Arg Xaa Xaa Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 410
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 410
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Xaa Xaa Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 411
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 411
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Lys Xaa Xaa Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 412
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 412
Xaa Ala Gly Xaa Pro Arg Arg Ile Ile Xaa Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 413
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 413
Xaa Ala Glu Xaa Pro His Arg Ile Ile Xaa Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 414
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 414
Xaa Gln Xaa Ala Ser Arg Leu Lys Xaa Xaa Leu His Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 415
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 415
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Leu Xaa Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 416
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 416
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Leu 
1               5                   10                  15      


Xaa Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 417
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 417
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Tyr Xaa Xaa Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 418
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 418
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Gln Xaa Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 419
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 419
Xaa Ala Ser Xaa Gln Lys Arg Leu Gln Xaa Xaa Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 420
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<400> 420
Ala Lys Lys Xaa Phe Ser Thr Val Arg Xaa Xaa Xaa Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 421
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 421
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Ala Xaa Xaa 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 422
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 422
Xaa Ala Xaa Ser Arg Arg Leu Xaa Xaa Xaa Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 423
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 423
Xaa Xaa Xaa Ser Xaa Arg Val Val Xaa Xaa Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 424
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 424
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Leu Xaa Xaa Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 425
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 425
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 426
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 426
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 427
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 427
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Asp Xaa Xaa Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 428
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 428
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Xaa Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 429
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 429
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Xaa Xaa Tyr Lys 
1               5                   10                  


<210> 430
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 430
Xaa Xaa Leu Lys Arg Ile Asn Xaa Xaa Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 431
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 431
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Arg Xaa Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 432
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 432
Xaa Ala Asn Ile Xaa Val Gln Arg Ile Lys Arg Xaa Phe Xaa Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 433
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 433
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Xaa Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 434
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 434
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Arg Arg Xaa Leu Xaa Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 435
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 435
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Xaa Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 436
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 436
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Leu Leu Xaa 
1               5                   10                  15      


Leu Xaa Gly Leu Gln Glu Glu 
            20              


<210> 437
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 437
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Xaa Ser Leu Gln Glu Glu 
            20              


<210> 438
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 438
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 439
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 439
Xaa Xaa Leu Lys Arg Ile His Lys Xaa Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 440
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 440
Xaa Xaa Leu Lys Arg Ile Asn Lys Xaa Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 441
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 441
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 442
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 442
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Thr Leu Asp 
            20              


<210> 443
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 443
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 444
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 444
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 445
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 445
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Arg Asp Xaa Cys Xaa Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 446
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 446
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Xaa Ala Xaa Glu Leu Lys Asp Pro 
            20                  25  


<210> 447
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 447
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln Xaa Tyr Xaa Arg Ile Lys Lys Asp 
            20                  25          


<210> 448
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 448
Xaa Ala Gly Xaa Pro Arg Arg Ile Ile Lys Xaa Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 449
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 449
Xaa Ala Glu Xaa Pro His Arg Ile Ile Lys Xaa Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 450
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 450
Xaa Gln Xaa Ala Ser Arg Leu Lys Arg Xaa Leu Xaa Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 451
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 451
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu Xaa Leu Xaa Glu Gly Gln Lys Gly 
            20                  25          


<210> 452
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 452
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu Xaa Leu Xaa Glu Gly Gln Lys Gly 
            20                  25  


<210> 453
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Non-natural electrophile containing amino acid or absent 

<400> 453
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys Xaa Val Xaa Thr Leu Thr Ala Asp 
            20                  25      


<210> 454
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 454
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Gln Gln Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 455
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 455
Xaa Ala Ser Xaa Gln Lys Arg Leu Gln Lys Xaa Leu Xaa Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 456
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 456
Ala Lys Lys Xaa Phe Ser Thr Val Arg Lys Xaa Xaa Xaa Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 457
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 457
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Ala Gln Xaa 
1               5                   10                  15      


Ala Xaa Thr Leu Ser Thr Ser 
            20              


<210> 458
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 458
Xaa Ala Xaa Ser Arg Arg Leu Xaa Lys Xaa Leu Xaa Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 459
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 459
Xaa Xaa Xaa Ser Xaa Arg Val Val Lys Xaa Leu Xaa Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 460
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 460
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Leu Ala Xaa Phe Xaa Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 461
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 461
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 462
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 462
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 463
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<400> 463
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Asp Thr Xaa Val Xaa 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 464
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 464
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 465
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 465
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Xaa 
1               5                   10                  


<210> 466
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 466
Xaa Xaa Leu Lys Arg Ile Asn Arg Xaa Leu Xaa Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 467
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 467
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Arg Lys Xaa Leu Xaa Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 468
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 468
Xaa Ala Asn Xaa Ala Val Gln Arg Ile Lys Xaa Glu Phe Xaa Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 469
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 469
Xaa Ser Thr Xaa Ala Arg Arg Arg Leu Xaa Xaa Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 470
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 470
Xaa Thr Glu Leu Xaa Ser Ala Leu Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 471
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 471
Xaa Ala Gly Xaa Ala Leu Lys Arg Leu Xaa Xaa Glu Tyr Xaa Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 472
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 472
Xaa Ala Arg Pro Leu Val Pro Xaa Ser Gln Lys Ala Leu Leu Xaa Glu 
1               5                   10                  15      


Leu Xaa Gly Leu Gln Glu Glu 
            20              


<210> 473
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 473
Xaa Ala Gln Gln Gln Xaa Thr Xaa Ser Gln Lys Ala Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Ser Leu Gln Glu Glu 
            20              


<210> 474
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 474
Xaa Ala Leu Lys Arg Ile Gln Xaa Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 475
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 475
Xaa Ala Leu Lys Arg Ile His Xaa Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 476
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 476
Xaa Ala Leu Lys Arg Ile Asn Xaa Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 477
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 477
Xaa Ala Leu Lys Arg Ile Gln Xaa Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 478
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 478
Lys Asn Ser Lys Leu Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Thr Leu Asp 
            20              


<210> 479
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 479
Lys Thr Ala Ala Lys Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 480
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 480
Lys Thr Thr Ala Lys Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 481
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 481
Xaa His Gly Arg Xaa Tyr Leu Leu Leu His Arg Xaa Phe Cys Xaa Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 482
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 482
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Xaa Ala Val Lys Arg Leu Xaa 
1               5                   10                  15      


Xaa Glu Ala Xaa Glu Leu Lys Asp Pro 
            20                  25  


<210> 483
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 483
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Xaa Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Xaa Asp Tyr Xaa Arg Ile Lys Lys Asp 
            20                  25          


<210> 484
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 484
Xaa Ala Xaa Leu Pro Arg Arg Ile Ile Xaa Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 485
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 485
Xaa Ala Xaa Leu Pro His Arg Ile Ile Xaa Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 486
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 486
Xaa Xaa Arg Ala Ser Arg Leu Lys Xaa Glu Leu Xaa Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 487
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 487
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Xaa Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Xaa Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25          


<210> 488
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 488
Xaa Ala Val Ser Thr Gly Val Lys Val Xaa Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Xaa Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25  


<210> 489
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Non-natural electrophile containing amino acid or absent 

<400> 489
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro Xaa Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Xaa Glu Val Xaa Thr Leu Thr Ala Asp 
            20                  25      


<210> 490
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 490
Ala Arg Gly Xaa Val Gly Lys Arg Leu Gln Xaa Glu Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 491
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 491
Xaa Ala Xaa Xaa Gln Lys Arg Leu Gln Xaa Glu Leu Xaa Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 492
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 492
Ala Lys Xaa Phe Phe Ser Thr Val Arg Xaa Glu Xaa Xaa Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 493
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 493
Ala Asn Asp Ala Asn Ser Ala Xaa Arg Ala Arg Arg Leu Ala Xaa Glu 
1               5                   10                  15      


Ala Xaa Thr Leu Ser Thr Ser 
            20              


<210> 494
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 494
Xaa Xaa Ala Ser Arg Arg Leu Xaa Xaa Glu Leu Xaa Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 495
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 495
Xaa Xaa Ala Ser Xaa Arg Val Val Xaa Glu Leu Xaa Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 496
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 496
Gly Pro Phe Xaa Leu Glu Tyr Ser Leu Leu Xaa Glu Phe Xaa Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 497
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 497
Gly Ala Val Ser Gly Ser Val Xaa Ala Thr Asp Arg Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 498
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 498
Gly Ala Val Ser Gly Ser Val Xaa Ala Ser Asp Arg Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 499
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<400> 499
Xaa Ser Ser Pro Ser Xaa Gly Lys Arg Arg Xaa Asp Xaa Asp Val Xaa 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 500
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 500
Xaa Ser Thr Xaa Ala Arg Arg Arg Leu Xaa Xaa Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 501
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 501
Xaa Ala Gly Xaa Ala Leu Lys Arg Leu Xaa Xaa Glu Tyr Xaa 
1               5                   10                  


<210> 502
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 502
Xaa Ala Leu Lys Arg Ile Asn Xaa Glu Leu Xaa Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 503
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 503
Xaa Pro Ser Ser Xaa Ser Glu Gln Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 504
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 504
Xaa Ala Asn Ile Ala Xaa Val Gln Arg Ile Xaa Arg Xaa Phe Lys Glu 
1               5                   10                  15      


Val Leu Lys Ser 
            20  


<210> 505
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 505
Xaa Ser Thr Pro Ala Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg 
1               5                   10                  15      


Leu Gln Glu Asp 
            20  


<210> 506
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 506
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Xaa Arg Xaa Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 507
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 507
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 508
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 508
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 509
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 509
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 510
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 510
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 511
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 511
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 512
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 512
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 513
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 513
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 514
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 514
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 515
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 515
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 516
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 516
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 517
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 517
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Xaa Asp Xaa Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 518
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 518
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Xaa Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 519
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 519
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Xaa Gln Xaa Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 520
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 520
Xaa Ala Gly Xaa Pro Arg Arg Ile Xaa Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 521
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 521
Xaa Ala Glu Xaa Pro His Arg Ile Xaa Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 522
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 522
Xaa Gln Xaa Ala Ser Arg Leu Xaa Arg Xaa Leu His Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 523
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 523
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Xaa Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 524
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 524
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Xaa 
1               5                   10                  15      


Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 525
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<400> 525
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Xaa Lys Xaa Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 526
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 526
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Xaa Gln Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 527
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 527
Xaa Ala Ser Xaa Gln Lys Arg Leu Xaa Lys Xaa Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 528
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<400> 528
Ala Lys Lys Xaa Phe Ser Thr Val Xaa Lys Xaa Xaa Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 529
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 529
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Xaa Gln Xaa 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 530
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 530
Xaa Ala Xaa Ser Arg Arg Leu Xaa Lys Xaa Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 531
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 531
Xaa Xaa Xaa Ser Xaa Arg Val Xaa Lys Xaa Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 532
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 532
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Xaa Ala Xaa Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 533
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 533
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 534
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 534
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 535
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<400> 535
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Xaa Thr Xaa Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 536
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 536
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 537
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 537
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys 
1               5                   10                  


<210> 538
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 538
Xaa Xaa Leu Lys Arg Ile Xaa Arg Xaa Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 539
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 539
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Xaa Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 540
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 540
Xaa Ala Asn Ile Xaa Val Gln Arg Ile Lys Xaa Xaa Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 541
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 541
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Xaa Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 542
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 542
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Arg Xaa Xaa Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 543
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 543
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Xaa Xaa Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 544
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 544
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Leu Xaa Xaa 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 545
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 545
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 546
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 546
Xaa Xaa Leu Lys Arg Ile Gln Xaa Xaa Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 547
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 547
Xaa Xaa Leu Lys Arg Ile His Xaa Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 548
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 548
Xaa Xaa Leu Lys Arg Ile Asn Xaa Xaa Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 549
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 549
Xaa Xaa Leu Lys Arg Ile Gln Xaa Xaa Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 550
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 550
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 551
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 551
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 552
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 552
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 553
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 553
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Arg Xaa Xaa Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 554
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 554
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Xaa Xaa Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 555
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 555
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Lys Xaa Xaa Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 556
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 556
Xaa Ala Gly Xaa Pro Arg Arg Ile Ile Xaa Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 557
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 557
Xaa Ala Glu Xaa Pro His Arg Ile Ile Xaa Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 558
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 558
Xaa Gln Xaa Ala Ser Arg Leu Lys Xaa Xaa Leu His Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 559
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 559
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Leu Xaa Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 560
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 560
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Leu 
1               5                   10                  15      


Xaa Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 561
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<400> 561
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Tyr Xaa Xaa Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 562
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 562
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Gln Xaa Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 563
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 563
Xaa Ala Ser Xaa Gln Lys Arg Leu Gln Xaa Xaa Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 564
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<400> 564
Ala Lys Lys Xaa Phe Ser Thr Val Arg Xaa Xaa Xaa Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 565
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 565
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Ala Xaa Xaa 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 566
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 566
Xaa Ala Xaa Ser Arg Arg Leu Xaa Xaa Xaa Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 567
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 567
Xaa Xaa Xaa Ser Xaa Arg Val Val Xaa Xaa Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 568
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 568
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Leu Xaa Xaa Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 569
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 569
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 570
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 570
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 571
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<400> 571
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Asp Xaa Xaa Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 572
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 572
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Xaa Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 573
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 573
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Xaa Xaa Tyr Lys 
1               5                   10                  


<210> 574
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 574
Xaa Xaa Leu Lys Arg Ile Asn Xaa Xaa Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 575
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 575
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Arg Xaa Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 576
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 576
Xaa Ala Asn Ile Xaa Val Gln Arg Ile Lys Arg Xaa Phe Xaa Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 577
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 577
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Xaa Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 578
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 578
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Arg Arg Xaa Leu Xaa Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 579
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 579
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Xaa Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 580
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 580
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Leu Leu Xaa 
1               5                   10                  15      


Leu Xaa Gly Leu Gln Glu Glu 
            20              


<210> 581
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 581
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Xaa Ser Leu Gln Glu Glu 
            20              


<210> 582
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 582
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 583
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 583
Xaa Xaa Leu Lys Arg Ile His Lys Xaa Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 584
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 584
Xaa Xaa Leu Lys Arg Ile Asn Lys Xaa Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 585
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 585
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 586
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 586
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Thr Leu Asp 
            20              


<210> 587
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 587
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 588
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 588
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 589
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 589
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Arg Asp Xaa Cys Xaa Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 590
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 590
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Xaa Ala Xaa Glu Leu Lys Asp Pro 
            20                  25  


<210> 591
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 591
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln Xaa Tyr Xaa Arg Ile Lys Lys Asp 
            20                  25          


<210> 592
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 592
Xaa Ala Gly Xaa Pro Arg Arg Ile Ile Lys Xaa Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 593
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 593
Xaa Ala Glu Xaa Pro His Arg Ile Ile Lys Xaa Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 594
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 594
Xaa Gln Xaa Ala Ser Arg Leu Lys Arg Xaa Leu Xaa Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 595
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 595
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu Xaa Leu Xaa Glu Gly Gln Lys Gly 
            20                  25          


<210> 596
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 596
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu Xaa Leu Xaa Glu Gly Gln Lys Gly 
            20                  25  


<210> 597
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Non-natural electrophile containing amino acid or absent 

<400> 597
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys Xaa Val Xaa Thr Leu Thr Ala Asp 
            20                  25      


<210> 598
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 598
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Gln Gln Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 599
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 599
Xaa Ala Ser Xaa Gln Lys Arg Leu Gln Lys Xaa Leu Xaa Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 600
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 600
Ala Lys Lys Xaa Phe Ser Thr Val Arg Lys Xaa Xaa Xaa Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 601
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 601
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Ala Gln Xaa 
1               5                   10                  15      


Ala Xaa Thr Leu Ser Thr Ser 
            20              


<210> 602
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 602
Xaa Ala Xaa Ser Arg Arg Leu Xaa Lys Xaa Leu Xaa Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 603
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 603
Xaa Xaa Xaa Ser Xaa Arg Val Val Lys Xaa Leu Xaa Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 604
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 604
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Leu Ala Xaa Phe Xaa Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 605
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 605
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 606
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 606
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 607
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<400> 607
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Asp Thr Xaa Val Xaa 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 608
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 608
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 609
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 609
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Xaa 
1               5                   10                  


<210> 610
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 610
Xaa Xaa Leu Lys Arg Ile Asn Arg Xaa Leu Xaa Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 611
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 611
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Arg Lys Xaa Leu Xaa Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 612
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 612
Xaa Ala Asn Xaa Ala Val Gln Arg Ile Lys Xaa Glu Phe Xaa Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 613
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 613
Xaa Ser Thr Xaa Ala Arg Arg Arg Leu Xaa Xaa Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 614
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 614
Xaa Thr Glu Leu Xaa Ser Ala Leu Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 615
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 615
Xaa Ala Gly Xaa Ala Leu Lys Arg Leu Xaa Xaa Glu Tyr Xaa Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 616
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 616
Xaa Ala Arg Pro Leu Val Pro Xaa Ser Gln Lys Ala Leu Leu Xaa Glu 
1               5                   10                  15      


Leu Xaa Gly Leu Gln Glu Glu 
            20              


<210> 617
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 617
Xaa Ala Gln Gln Gln Xaa Thr Xaa Ser Gln Lys Ala Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Ser Leu Gln Glu Glu 
            20              


<210> 618
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 618
Xaa Ala Leu Lys Arg Ile Gln Xaa Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 619
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 619
Xaa Ala Leu Lys Arg Ile His Xaa Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 620
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 620
Xaa Ala Leu Lys Arg Ile Asn Xaa Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 621
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 621
Xaa Ala Leu Lys Arg Ile Gln Xaa Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 622
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 622
Lys Asn Ser Lys Leu Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Thr Leu Asp 
            20              


<210> 623
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 623
Lys Thr Ala Ala Lys Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 624
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 624
Lys Thr Thr Ala Lys Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 625
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 625
Xaa His Gly Arg Xaa Tyr Leu Leu Leu His Arg Xaa Phe Cys Xaa Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 626
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 626
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Xaa Ala Val Lys Arg Leu Xaa 
1               5                   10                  15      


Xaa Glu Ala Xaa Glu Leu Lys Asp Pro 
            20                  25  


<210> 627
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 627
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Xaa Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Xaa Asp Tyr Xaa Arg Ile Lys Lys Asp 
            20                  25          


<210> 628
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 628
Xaa Ala Xaa Leu Pro Arg Arg Ile Ile Xaa Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 629
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 629
Xaa Ala Xaa Leu Pro His Arg Ile Ile Xaa Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 630
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 630
Xaa Xaa Arg Ala Ser Arg Leu Lys Xaa Glu Leu Xaa Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 631
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Non-natural electrophile containing amino acid or absent 

<400> 631
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Xaa Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Xaa Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25          


<210> 632
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Non-natural electrophile containing amino acid or absent 

<400> 632
Xaa Ala Val Ser Thr Gly Val Lys Val Xaa Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Xaa Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25  


<210> 633
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Non-natural electrophile containing amino acid or absent 

<400> 633
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro Xaa Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Xaa Glu Val Xaa Thr Leu Thr Ala Asp 
            20                  25      


<210> 634
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 634
Ala Arg Gly Xaa Val Gly Lys Arg Leu Gln Xaa Glu Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 635
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 635
Xaa Ala Xaa Xaa Gln Lys Arg Leu Gln Xaa Glu Leu Xaa Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 636
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural electrophile containing amino acid or absent 

<400> 636
Ala Lys Xaa Phe Phe Ser Thr Val Arg Xaa Glu Xaa Xaa Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 637
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 637
Ala Asn Asp Ala Asn Ser Ala Xaa Arg Ala Arg Arg Leu Ala Xaa Glu 
1               5                   10                  15      


Ala Xaa Thr Leu Ser Thr Ser 
            20              


<210> 638
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 638
Xaa Xaa Ala Ser Arg Arg Leu Xaa Xaa Glu Leu Xaa Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 639
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 639
Xaa Xaa Ala Ser Xaa Arg Val Val Xaa Glu Leu Xaa Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 640
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 640
Gly Pro Phe Xaa Leu Glu Tyr Ser Leu Leu Xaa Glu Phe Xaa Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 641
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 641
Gly Ala Val Ser Gly Ser Val Xaa Ala Thr Asp Arg Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 642
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Non-natural electrophile containing amino acid or absent 

<400> 642
Gly Ala Val Ser Gly Ser Val Xaa Ala Ser Asp Arg Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 643
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural electrophile containing amino acid or absent 

<400> 643
Xaa Ser Ser Pro Ser Xaa Gly Lys Arg Arg Xaa Asp Xaa Asp Val Xaa 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 644
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 644
Xaa Ser Thr Xaa Ala Arg Arg Arg Leu Xaa Xaa Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 645
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Non-natural electrophile containing amino acid or absent 

<400> 645
Xaa Ala Gly Xaa Ala Leu Lys Arg Leu Xaa Xaa Glu Tyr Xaa 
1               5                   10                  


<210> 646
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 646
Xaa Ala Leu Lys Arg Ile Asn Xaa Glu Leu Xaa Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 647
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 647
Xaa Pro Ser Ser Xaa Ser Glu Gln Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 648
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 648
Xaa Ala Asn Ile Ala Xaa Val Gln Arg Ile Xaa Arg Xaa Phe Lys Glu 
1               5                   10                  15      


Val Leu Lys Ser 
            20  


<210> 649
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 649
Xaa Ser Thr Pro Ala Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg 
1               5                   10                  15      


Leu Gln Glu Asp 
            20  


<210> 650
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 650
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Xaa Arg Xaa Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 651
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 651
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 652
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 652
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 653
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 653
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 654
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 654
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 655
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 655
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 656
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 656
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 657
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 657
Xaa Xaa Leu Lys Arg Ile Xaa Lys Xaa Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 658
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 658
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 659
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 659
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 660
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 660
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Xaa Lys Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 661
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 661
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Xaa Asp Xaa Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 662
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 662
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Xaa Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 663
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 663
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Xaa Gln Xaa Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 664
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 664
Xaa Ala Gly Xaa Pro Arg Arg Ile Xaa Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 665
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 665
Xaa Ala Glu Xaa Pro His Arg Ile Xaa Lys Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 666
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 666
Xaa Gln Xaa Ala Ser Arg Leu Xaa Arg Xaa Leu His Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 667
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 667
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Xaa Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 668
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 668
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Xaa 
1               5                   10                  15      


Glu Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 669
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<400> 669
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Xaa Lys Xaa Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 670
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 670
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Xaa Gln Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 671
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 671
Xaa Ala Ser Xaa Gln Lys Arg Leu Xaa Lys Xaa Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 672
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<400> 672
Ala Lys Lys Xaa Phe Ser Thr Val Xaa Lys Xaa Xaa Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 673
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 673
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Xaa Gln Xaa 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 674
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 674
Xaa Ala Xaa Ser Arg Arg Leu Xaa Lys Xaa Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 675
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 675
Xaa Xaa Xaa Ser Xaa Arg Val Xaa Lys Xaa Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 676
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 676
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Xaa Ala Xaa Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 677
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 677
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 678
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 678
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 679
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<400> 679
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Xaa Thr Xaa Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 680
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine or R-octenyl alanine 

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 680
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 681
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 681
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys 
1               5                   10                  


<210> 682
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 682
Xaa Xaa Leu Lys Arg Ile Xaa Arg Xaa Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 683
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 683
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Xaa Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 684
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 684
Xaa Ala Asn Ile Xaa Val Gln Arg Ile Lys Xaa Xaa Phe Lys Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 685
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 685
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Xaa Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 686
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 686
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Arg Xaa Xaa Leu Ala Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 687
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 687
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Xaa Xaa Tyr Lys Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 688
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 688
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Leu Xaa Xaa 
1               5                   10                  15      


Leu Lys Gly Leu Gln Glu Glu 
            20              


<210> 689
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 689
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Lys Ser Leu Gln Glu Glu 
            20              


<210> 690
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 690
Xaa Xaa Leu Lys Arg Ile Gln Xaa Xaa Leu Ser Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 691
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine or R-octenyl alanine 

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 691
Xaa Xaa Leu Lys Arg Ile His Xaa Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 692
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 692
Xaa Xaa Leu Lys Arg Ile Asn Xaa Xaa Leu Ser Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 693
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 693
Xaa Xaa Leu Lys Arg Ile Gln Xaa Xaa Leu Thr Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 694
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 694
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Asp Ile Thr Leu Asp 
            20              


<210> 695
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 695
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 696
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 696
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Xaa Xaa 
1               5                   10                  15      


Leu Ala Glu Ile Thr Leu Asp 
            20              


<210> 697
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 697
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Arg Xaa Xaa Cys Asp Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 698
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 698
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Xaa Xaa Ala Ala Glu Leu Lys Asp Pro 
            20                  25  


<210> 699
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 699
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Lys Xaa Xaa Tyr Leu Arg Ile Lys Lys Asp 
            20                  25          


<210> 700
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 700
Xaa Ala Gly Xaa Pro Arg Arg Ile Ile Xaa Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 701
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 701
Xaa Ala Glu Xaa Pro His Arg Ile Ile Xaa Xaa Thr Gln Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 702
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 702
Xaa Gln Xaa Ala Ser Arg Leu Lys Xaa Xaa Leu His Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 703
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<400> 703
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Leu Xaa Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25          


<210> 704
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<400> 704
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Leu 
1               5                   10                  15      


Xaa Xaa Leu Glu Glu Gly Gln Lys Gly 
            20                  25  


<210> 705
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<400> 705
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Tyr Xaa Xaa Val Thr Thr Leu Thr Ala Asp 
            20                  25      


<210> 706
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 706
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Gln Xaa Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 707
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<400> 707
Xaa Ala Ser Xaa Gln Lys Arg Leu Gln Xaa Xaa Leu Leu Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 708
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<400> 708
Ala Lys Lys Xaa Phe Ser Thr Val Arg Xaa Xaa Xaa Ala Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 709
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 709
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Ala Xaa Xaa 
1               5                   10                  15      


Ala Val Thr Leu Ser Thr Ser 
            20              


<210> 710
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 710
Xaa Ala Xaa Ser Arg Arg Leu Xaa Xaa Xaa Leu Glu Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 711
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<400> 711
Xaa Xaa Xaa Ser Xaa Arg Val Val Xaa Xaa Leu Glu Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 712
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 712
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Leu Xaa Xaa Phe Thr Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 713
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 713
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 714
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<400> 714
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Xaa Xaa 
1               5                   10                  15      


Leu Arg Asp Ile Tyr Arg Ser 
            20              


<210> 715
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<400> 715
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Asp Xaa Xaa Val Val 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 716
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 716
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Xaa Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 717
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 717
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Xaa Xaa Tyr Lys 
1               5                   10                  


<210> 718
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 718
Xaa Xaa Leu Lys Arg Ile Asn Xaa Xaa Leu Ala Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 719
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 719
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Arg Xaa Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 720
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 720
Xaa Ala Asn Ile Xaa Val Gln Arg Ile Lys Arg Xaa Phe Xaa Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 721
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 721
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Xaa Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 722
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 722
Xaa Thr Glu Leu Gln Xaa Ala Leu Leu Leu Arg Arg Xaa Leu Xaa Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 723
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 723
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Xaa Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 724
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 724
Xaa Ala Arg Pro Leu Val Pro Ser Xaa Gln Lys Ala Leu Leu Leu Xaa 
1               5                   10                  15      


Leu Xaa Gly Leu Gln Glu Glu 
            20              


<210> 725
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 725
Xaa Ala Gln Gln Gln Xaa Thr Ser Xaa Gln Lys Ala Leu Xaa Leu Xaa 
1               5                   10                  15      


Leu Xaa Ser Leu Gln Glu Glu 
            20              


<210> 726
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 726
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 727
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 727
Xaa Xaa Leu Lys Arg Ile His Lys Xaa Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 728
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 728
Xaa Xaa Leu Lys Arg Ile Asn Lys Xaa Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 729
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 729
Xaa Xaa Leu Lys Arg Ile Gln Lys Xaa Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 730
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 730
Lys Asn Ser Lys Leu Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Thr Leu Asp 
            20              


<210> 731
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 731
Lys Thr Ala Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 732
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 732
Lys Thr Thr Ala Lys Leu Ser Thr Xaa Ala Lys Arg Ile Gln Lys Xaa 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 733
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 733
Xaa His Gly Arg Ala Xaa Leu Leu Leu His Arg Asp Xaa Cys Xaa Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 734
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 734
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Pro Xaa Val Lys Arg Leu Xaa 
1               5                   10                  15      


Lys Xaa Ala Xaa Glu Leu Lys Asp Pro 
            20                  25  


<210> 735
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 735
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Xaa Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln Xaa Tyr Xaa Arg Ile Lys Lys Asp 
            20                  25          


<210> 736
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 736
Xaa Ala Gly Xaa Pro Arg Arg Ile Ile Lys Xaa Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 737
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 737
Xaa Ala Glu Xaa Pro His Arg Ile Ile Lys Xaa Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 738
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 738
Xaa Gln Xaa Ala Ser Arg Leu Lys Arg Xaa Leu Xaa Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 739
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 739
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Xaa Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu Xaa Leu Xaa Glu Gly Gln Lys Gly 
            20                  25          


<210> 740
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 740
Xaa Ala Val Ser Thr Gly Val Lys Val Pro Xaa Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu Xaa Leu Xaa Glu Gly Gln Lys Gly 
            20                  25  


<210> 741
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 741
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro His Xaa Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys Xaa Val Xaa Thr Leu Thr Ala Asp 
            20                  25      


<210> 742
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 742
Ala Arg Gly Pro Xaa Gly Lys Arg Leu Gln Gln Xaa Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 743
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 743
Xaa Ala Ser Xaa Gln Lys Arg Leu Gln Lys Xaa Leu Xaa Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 744
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 744
Ala Lys Lys Xaa Phe Ser Thr Val Arg Lys Xaa Xaa Xaa Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 745
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 745
Ala Asn Asp Ala Asn Ser Ala Ala Xaa Ala Arg Arg Leu Ala Gln Xaa 
1               5                   10                  15      


Ala Xaa Thr Leu Ser Thr Ser 
            20              


<210> 746
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 746
Xaa Ala Xaa Ser Arg Arg Leu Xaa Lys Xaa Leu Xaa Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 747
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 747
Xaa Xaa Xaa Ser Xaa Arg Val Val Lys Xaa Leu Xaa Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 748
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 748
Gly Pro Phe Tyr Xaa Glu Tyr Ser Leu Leu Ala Xaa Phe Xaa Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 749
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 749
Gly Ala Val Ser Gly Ser Val Gln Xaa Thr Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 750
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 750
Gly Ala Val Ser Gly Ser Val Gln Xaa Ser Asp Arg Leu Xaa Lys Xaa 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 751
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 751
Xaa Ser Ser Pro Ser Pro Xaa Lys Arg Arg Xaa Asp Thr Xaa Val Xaa 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 752
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 752
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 753
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 753
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Xaa 
1               5                   10                  


<210> 754
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 754
Xaa Xaa Leu Lys Arg Ile Asn Arg Xaa Leu Xaa Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 755
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 755
Xaa Pro Ser Ser Ala Xaa Glu Gln Leu Leu Arg Lys Xaa Leu Xaa Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 756
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 756
Xaa Ala Asn Xaa Ala Val Gln Arg Ile Lys Xaa Glu Phe Xaa Glu Val 
1               5                   10                  15      


Leu Lys Ser 
            


<210> 757
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 757
Xaa Ser Thr Xaa Ala Arg Arg Arg Leu Xaa Xaa Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln Glu Asp 
            


<210> 758
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 758
Xaa Thr Glu Leu Xaa Ser Ala Leu Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Leu Asn Lys Asn 
            20  


<210> 759
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 759
Xaa Ala Gly Xaa Ala Leu Lys Arg Leu Xaa Xaa Glu Tyr Xaa Gln Leu 
1               5                   10                  15      


Thr Leu Asn 
            


<210> 760
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 760
Xaa Ala Arg Pro Leu Val Pro Xaa Ser Gln Lys Ala Leu Leu Xaa Glu 
1               5                   10                  15      


Leu Xaa Gly Leu Gln Glu Glu 
            20              


<210> 761
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 761
Xaa Ala Gln Gln Gln Xaa Thr Xaa Ser Gln Lys Ala Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Ser Leu Gln Glu Glu 
            20              


<210> 762
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 762
Xaa Ala Leu Lys Arg Ile Gln Xaa Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 763
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 763
Xaa Ala Leu Lys Arg Ile His Xaa Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 764
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 764
Xaa Ala Leu Lys Arg Ile Asn Xaa Glu Leu Xaa Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 765
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 765
Xaa Ala Leu Lys Arg Ile Gln Xaa Glu Leu Xaa Asp Leu Gln Arg Asp 
1               5                   10                  15      


<210> 766
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 766
Lys Asn Ser Lys Leu Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Thr Leu Asp 
            20              


<210> 767
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 767
Lys Thr Ala Ala Lys Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 768
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 768
Lys Thr Thr Ala Lys Leu Ser Xaa Ser Ala Lys Arg Ile Gln Xaa Glu 
1               5                   10                  15      


Leu Xaa Glu Ile Thr Leu Asp 
            20              


<210> 769
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 769
Xaa His Gly Arg Xaa Tyr Leu Leu Leu His Arg Xaa Phe Cys Xaa Leu 
1               5                   10                  15      


Lys Glu Asn Asn 
            20  


<210> 770
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 770
Xaa Glu Thr Arg Tyr Asn Leu Lys Ser Xaa Ala Val Lys Arg Leu Xaa 
1               5                   10                  15      


Xaa Glu Ala Xaa Glu Leu Lys Asp Pro 
            20                  25  


<210> 771
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 771
Xaa Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Xaa Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Xaa Asp Tyr Xaa Arg Ile Lys Lys Asp 
            20                  25          


<210> 772
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 772
Xaa Ala Xaa Leu Pro Arg Arg Ile Ile Xaa Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 773
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 773
Xaa Ala Xaa Leu Pro His Arg Ile Ile Xaa Glu Thr Xaa Arg Leu Leu 
1               5                   10                  15      


Ala Glu 
        


<210> 774
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Norleucine 

<400> 774
Xaa Xaa Arg Ala Ser Arg Leu Lys Xaa Glu Leu Xaa Xaa Leu Ala Thr 
1               5                   10                  15      


Glu 
    


<210> 775
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 775
Xaa Ala Ala Thr Thr Gly Ser Gly Val Lys Val Xaa Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Xaa Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25          


<210> 776
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (17)..(17)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 776
Xaa Ala Val Ser Thr Gly Val Lys Val Xaa Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Xaa Glu Leu Xaa Glu Gly Gln Lys Gly 
            20                  25  


<210> 777
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 777
Xaa Asn Ser Asn Val Glu Asn Leu Pro Pro Xaa Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Xaa Glu Val Xaa Thr Leu Thr Ala Asp 
            20                  25      


<210> 778
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Norleucine 

<400> 778
Ala Arg Gly Xaa Val Gly Lys Arg Leu Gln Xaa Glu Leu Xaa Thr Leu 
1               5                   10                  15      


Xaa Xaa Ser 
            


<210> 779
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 779
Xaa Ala Xaa Xaa Gln Lys Arg Leu Gln Xaa Glu Leu Xaa Ala Leu Gln 
1               5                   10                  15      


Asn Asp 
        


<210> 780
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (3)..(3)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 780
Ala Lys Xaa Phe Phe Ser Thr Val Arg Xaa Glu Xaa Xaa Leu Leu Ala 
1               5                   10                  15      


Thr Ser 
        


<210> 781
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 781
Ala Asn Asp Ala Asn Ser Ala Xaa Arg Ala Arg Arg Leu Ala Xaa Glu 
1               5                   10                  15      


Ala Xaa Thr Leu Ser Thr Ser 
            20              


<210> 782
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 782
Xaa Xaa Ala Ser Arg Arg Leu Xaa Xaa Glu Leu Xaa Glu Ile Arg Lys 
1               5                   10                  15      


Cys 
    


<210> 783
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 783
Xaa Xaa Ala Ser Xaa Arg Val Val Xaa Glu Leu Xaa Asp Leu Gln Lys 
1               5                   10                  15      


Lys 
    


<210> 784
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 784
Gly Pro Phe Xaa Leu Glu Tyr Ser Leu Leu Xaa Glu Phe Xaa Leu Val 
1               5                   10                  15      


Val Lys Gln 
            


<210> 785
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 785
Gly Ala Val Ser Gly Ser Val Xaa Ala Thr Asp Arg Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 786
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 786
Gly Ala Val Ser Gly Ser Val Xaa Ala Ser Asp Arg Leu Xaa Xaa Glu 
1               5                   10                  15      


Leu Xaa Asp Ile Tyr Arg Ser 
            20              


<210> 787
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 787
Xaa Ser Ser Pro Ser Xaa Gly Lys Arg Arg Xaa Asp Xaa Asp Val Xaa 
1               5                   10                  15      


Lys Leu Ile Glu Ser 
            20      


<210> 788
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 788
Xaa Ser Thr Xaa Ala Arg Arg Arg Leu Xaa Xaa Asp Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 789
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 789
Xaa Ala Gly Xaa Ala Leu Lys Arg Leu Xaa Xaa Glu Tyr Xaa 
1               5                   10                  


<210> 790
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 790
Xaa Ala Leu Lys Arg Ile Asn Xaa Glu Leu Xaa Asp Leu Gly Lys Asp 
1               5                   10                  15      


<210> 791
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 791
Xaa Pro Ser Ser Xaa Ser Glu Gln Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln Lys Asn 
            20  


<210> 792
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 792
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Glu Leu 
1               5                   10                  15      


Gln 
    


<210> 793
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 793
Met Ala Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 794
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 794
Met Ser Ala Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 795
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 795
Met Ser Thr Ala Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 796
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 796
Met Ser Thr Pro Ala Ala Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 797
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 797
Met Ser Thr Pro Ala Arg Ala Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 798
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 798
Met Ser Thr Pro Ala Arg Arg Ala Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 799
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 799
Met Ser Thr Pro Ala Arg Arg Arg Ala Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 800
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 800
Met Ser Thr Pro Ala Arg Arg Arg Leu Ala Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 801
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 801
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Ala Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 802
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 802
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Ala Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 803
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 803
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Ala Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 804
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 804
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Ala Leu 
1               5                   10                  15      


Gln 
    


<210> 805
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 805
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Ala 
1               5                   10                  15      


Gln 
    


<210> 806
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 806
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Ala 
    


<210> 807
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 807
Ala Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 808
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 808
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Arg Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 809
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 809
Xaa Ser Thr Pro Xaa Glu Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 810
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 810
Xaa Ser Thr Pro Xaa Arg Arg Glu Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 811
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 811
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Glu Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 812
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 812
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Glu Leu 
1               5                   10                  15      


Gln 
    


<210> 813
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 813
Xaa Ala Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 814
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 814
Xaa Ser Ala Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 815
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 815
Xaa Ser Thr Ala Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 816
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 816
Xaa Ser Thr Pro Xaa Ala Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 817
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 817
Xaa Ser Thr Pro Xaa Arg Ala Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 818
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 818
Xaa Ser Thr Pro Xaa Arg Arg Ala Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 819
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 819
Xaa Ser Thr Pro Xaa Arg Arg Arg Ala Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 820
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 820
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Ala Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 821
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 821
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Ala Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 822
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 822
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Ala Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 823
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 823
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Ala Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 824
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 824
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Ala Leu 
1               5                   10                  15      


Gln 
    


<210> 825
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 825
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Ala 
1               5                   10                  15      


Gln 
    


<210> 826
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine

<400> 826
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Ala 
    


<210> 827
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<400> 827
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Xaa Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 828
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<400> 828
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Xaa Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 829
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 829
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 830
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 830
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Xaa Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 831
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 831
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Xaa Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 832
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<400> 832
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 833
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 833
Xaa Pro Ser Ser Xaa Ser Arg Gln Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 834
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 834
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Xaa Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 835
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 835
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Xaa Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 836
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 836
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Lys Xaa Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 837
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 837
Xaa Pro Ser Ser Xaa Ser Arg Gln Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 838
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 838
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Xaa Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 839
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Non-natural electrophile containing amino acid or absent 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 839
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Xaa Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 840
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Non-natural electrophile containing amino acid or absent 

<400> 840
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Lys Xaa Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 841
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 841
Xaa Pro Ser Ser Xaa Ser Arg Gln Leu Leu Arg Xaa Gln Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 842
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine or R-octenyl alanine 

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 842
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Xaa Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 843
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 843
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Xaa Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 844
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine or R-octenyl alanine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Diamino butanoic acid terminating in acrylamide or diamino
      butanoic acid terminating in bromoacetyl

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 844
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Lys Xaa Leu Xaa Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 845
<211> 1058
<212> PRT
<213> Homo sapiens

<400> 845
Met Ser Ser Ser Pro Leu Ser Lys Lys Arg Arg Val Ser Gly Pro Asp 
1               5                   10                  15      


Pro Lys Pro Gly Ser Asn Cys Ser Pro Ala Gln Ser Val Leu Ser Glu 
            20                  25                  30          


Val Pro Ser Val Pro Thr Asn Gly Met Ala Lys Asn Gly Ser Glu Ala 
        35                  40                  45              


Asp Ile Asp Glu Gly Leu Tyr Ser Arg Gln Leu Tyr Val Leu Gly His 
    50                  55                  60                  


Glu Ala Met Lys Arg Leu Gln Thr Ser Ser Val Leu Val Ser Gly Leu 
65                  70                  75                  80  


Arg Gly Leu Gly Val Glu Ile Ala Lys Asn Ile Ile Leu Gly Gly Val 
                85                  90                  95      


Lys Ala Val Thr Leu His Asp Gln Gly Thr Ala Gln Trp Ala Asp Leu 
            100                 105                 110         


Ser Ser Gln Phe Tyr Leu Arg Glu Glu Asp Ile Gly Lys Asn Arg Ala 
        115                 120                 125             


Glu Val Ser Gln Pro Arg Leu Ala Glu Leu Asn Ser Tyr Val Pro Val 
    130                 135                 140                 


Thr Ala Tyr Thr Gly Pro Leu Val Glu Asp Phe Leu Ser Gly Phe Gln 
145                 150                 155                 160 


Val Val Val Leu Thr Asn Thr Pro Leu Glu Asp Gln Leu Arg Val Gly 
                165                 170                 175     


Glu Phe Cys His Asn Arg Gly Ile Lys Leu Val Val Ala Asp Thr Arg 
            180                 185                 190         


Gly Leu Phe Gly Gln Leu Phe Cys Asp Phe Gly Glu Glu Met Ile Leu 
        195                 200                 205             


Thr Asp Ser Asn Gly Glu Gln Pro Leu Ser Ala Met Val Ser Met Val 
    210                 215                 220                 


Thr Lys Asp Asn Pro Gly Val Val Thr Cys Leu Asp Glu Ala Arg His 
225                 230                 235                 240 


Gly Phe Glu Ser Gly Asp Phe Val Ser Phe Ser Glu Val Gln Gly Met 
                245                 250                 255     


Val Glu Leu Asn Gly Asn Gln Pro Met Glu Ile Lys Val Leu Gly Pro 
            260                 265                 270         


Tyr Thr Phe Ser Ile Cys Asp Thr Ser Asn Phe Ser Asp Tyr Ile Arg 
        275                 280                 285             


Gly Gly Ile Val Ser Gln Val Lys Val Pro Lys Lys Ile Ser Phe Lys 
    290                 295                 300                 


Ser Leu Val Ala Ser Leu Ala Glu Pro Asp Phe Val Val Thr Asp Phe 
305                 310                 315                 320 


Ala Lys Phe Ser Arg Pro Ala Gln Leu His Ile Gly Phe Gln Ala Leu 
                325                 330                 335     


His Gln Phe Cys Ala Gln His Gly Arg Pro Pro Arg Pro Arg Asn Glu 
            340                 345                 350         


Glu Asp Ala Ala Glu Leu Val Ala Leu Ala Gln Ala Val Asn Ala Arg 
        355                 360                 365             


Ala Leu Pro Ala Val Gln Gln Asn Asn Leu Asp Glu Asp Leu Ile Arg 
    370                 375                 380                 


Lys Leu Ala Tyr Val Ala Ala Gly Asp Leu Ala Pro Ile Asn Ala Phe 
385                 390                 395                 400 


Ile Gly Gly Leu Ala Ala Gln Glu Val Met Lys Ala Cys Ser Gly Lys 
                405                 410                 415     


Phe Met Pro Ile Met Gln Trp Leu Tyr Phe Asp Ala Leu Glu Cys Leu 
            420                 425                 430         


Pro Glu Asp Lys Glu Val Leu Thr Glu Asp Lys Cys Leu Gln Arg Gln 
        435                 440                 445             


Asn Arg Tyr Asp Gly Gln Val Ala Val Phe Gly Ser Asp Leu Gln Glu 
    450                 455                 460                 


Lys Leu Gly Lys Gln Lys Tyr Phe Leu Val Gly Ala Gly Ala Ile Gly 
465                 470                 475                 480 


Cys Glu Leu Leu Lys Asn Phe Ala Met Ile Gly Leu Gly Cys Gly Glu 
                485                 490                 495     


Gly Gly Glu Ile Ile Val Thr Asp Met Asp Thr Ile Glu Lys Ser Asn 
            500                 505                 510         


Leu Asn Arg Gln Phe Leu Phe Arg Pro Trp Asp Val Thr Lys Leu Lys 
        515                 520                 525             


Ser Asp Thr Ala Ala Ala Ala Val Arg Gln Met Asn Pro His Ile Arg 
    530                 535                 540                 


Val Thr Ser His Gln Asn Arg Val Gly Pro Asp Thr Glu Arg Ile Tyr 
545                 550                 555                 560 


Asp Asp Asp Phe Phe Gln Asn Leu Asp Gly Val Ala Asn Ala Leu Asp 
                565                 570                 575     


Asn Val Asp Ala Arg Met Tyr Met Asp Arg Arg Cys Val Tyr Tyr Arg 
            580                 585                 590         


Lys Pro Leu Leu Glu Ser Gly Thr Leu Gly Thr Lys Gly Asn Val Gln 
        595                 600                 605             


Val Val Ile Pro Phe Leu Thr Glu Ser Tyr Ser Ser Ser Gln Asp Pro 
    610                 615                 620                 


Pro Glu Lys Ser Ile Pro Ile Cys Thr Leu Lys Asn Phe Pro Asn Ala 
625                 630                 635                 640 


Ile Glu His Thr Leu Gln Trp Ala Arg Asp Glu Phe Glu Gly Leu Phe 
                645                 650                 655     


Lys Gln Pro Ala Glu Asn Val Asn Gln Tyr Leu Thr Asp Pro Lys Phe 
            660                 665                 670         


Val Glu Arg Thr Leu Arg Leu Ala Gly Thr Gln Pro Leu Glu Val Leu 
        675                 680                 685             


Glu Ala Val Gln Arg Ser Leu Val Leu Gln Arg Pro Gln Thr Trp Ala 
    690                 695                 700                 


Asp Cys Val Thr Trp Ala Cys His His Trp His Thr Gln Tyr Ser Asn 
705                 710                 715                 720 


Asn Ile Arg Gln Leu Leu His Asn Phe Pro Pro Asp Gln Leu Thr Ser 
                725                 730                 735     


Ser Gly Ala Pro Phe Trp Ser Gly Pro Lys Arg Cys Pro His Pro Leu 
            740                 745                 750         


Thr Phe Asp Val Asn Asn Pro Leu His Leu Asp Tyr Val Met Ala Ala 
        755                 760                 765             


Ala Asn Leu Phe Ala Gln Thr Tyr Gly Leu Thr Gly Ser Gln Asp Arg 
    770                 775                 780                 


Ala Ala Val Ala Thr Phe Leu Gln Ser Val Gln Val Pro Glu Phe Thr 
785                 790                 795                 800 


Pro Lys Ser Gly Val Lys Ile His Val Ser Asp Gln Glu Leu Gln Ser 
                805                 810                 815     


Ala Asn Ala Ser Val Asp Asp Ser Arg Leu Glu Glu Leu Lys Ala Thr 
            820                 825                 830         


Leu Pro Ser Pro Asp Lys Leu Pro Gly Phe Lys Met Tyr Pro Ile Asp 
        835                 840                 845             


Phe Glu Lys Asp Asp Asp Ser Asn Phe His Met Asp Phe Ile Val Ala 
    850                 855                 860                 


Ala Ser Asn Leu Arg Ala Glu Asn Tyr Asp Ile Pro Ser Ala Asp Arg 
865                 870                 875                 880 


His Lys Ser Lys Leu Ile Ala Gly Lys Ile Ile Pro Ala Ile Ala Thr 
                885                 890                 895     


Thr Thr Ala Ala Val Val Gly Leu Val Cys Leu Glu Leu Tyr Lys Val 
            900                 905                 910         


Val Gln Gly His Arg Gln Leu Asp Ser Tyr Lys Asn Gly Phe Leu Asn 
        915                 920                 925             


Leu Ala Leu Pro Phe Phe Gly Phe Ser Glu Pro Leu Ala Ala Pro Arg 
    930                 935                 940                 


His Gln Tyr Tyr Asn Gln Glu Trp Thr Leu Trp Asp Arg Phe Glu Val 
945                 950                 955                 960 


Gln Gly Leu Gln Pro Asn Gly Glu Glu Met Thr Leu Lys Gln Phe Leu 
                965                 970                 975     


Asp Tyr Phe Lys Thr Glu His Lys Leu Glu Ile Thr Met Leu Ser Gln 
            980                 985                 990         


Gly Val Ser Met Leu Tyr Ser Phe  Phe Met Pro Ala Ala  Lys Leu Lys 
        995                 1000                 1005             


Glu Arg  Leu Asp Gln Pro Met  Thr Glu Ile Val Ser  Arg Val Ser 
    1010                 1015                 1020             


Lys Arg  Lys Leu Gly Arg His  Val Arg Ala Leu Val  Leu Glu Leu 
    1025                 1030                 1035             


Cys Cys  Asn Asp Glu Ser Gly  Glu Asp Val Glu Val  Pro Tyr Val 
    1040                 1045                 1050             


Arg Tyr  Thr Ile Arg 
    1055             


<210> 846
<211> 640
<212> PRT
<213> Homo sapiens

<400> 846
Met Ala Leu Ser Arg Gly Leu Pro Arg Glu Leu Ala Glu Ala Val Ala 
1               5                   10                  15      


Gly Gly Arg Val Leu Val Val Gly Ala Gly Gly Ile Gly Cys Glu Leu 
            20                  25                  30          


Leu Lys Asn Leu Val Leu Thr Gly Phe Ser His Ile Asp Leu Ile Asp 
        35                  40                  45              


Leu Asp Thr Ile Asp Val Ser Asn Leu Asn Arg Gln Phe Leu Phe Gln 
    50                  55                  60                  


Lys Lys His Val Gly Arg Ser Lys Ala Gln Val Ala Lys Glu Ser Val 
65                  70                  75                  80  


Leu Gln Phe Tyr Pro Lys Ala Asn Ile Val Ala Tyr His Asp Ser Ile 
                85                  90                  95      


Met Asn Pro Asp Tyr Asn Val Glu Phe Phe Arg Gln Phe Ile Leu Val 
            100                 105                 110         


Met Asn Ala Leu Asp Asn Arg Ala Ala Arg Asn His Val Asn Arg Met 
        115                 120                 125             


Cys Leu Ala Ala Asp Val Pro Leu Ile Glu Ser Gly Thr Ala Gly Tyr 
    130                 135                 140                 


Leu Gly Gln Val Thr Thr Ile Lys Lys Gly Val Thr Glu Cys Tyr Glu 
145                 150                 155                 160 


Cys His Pro Lys Pro Thr Gln Arg Thr Phe Pro Gly Cys Thr Ile Arg 
                165                 170                 175     


Asn Thr Pro Ser Glu Pro Ile His Cys Ile Val Trp Ala Lys Tyr Leu 
            180                 185                 190         


Phe Asn Gln Leu Phe Gly Glu Glu Asp Ala Asp Gln Glu Val Ser Pro 
        195                 200                 205             


Asp Arg Ala Asp Pro Glu Ala Ala Trp Glu Pro Thr Glu Ala Glu Ala 
    210                 215                 220                 


Arg Ala Arg Ala Ser Asn Glu Asp Gly Asp Ile Lys Arg Ile Ser Thr 
225                 230                 235                 240 


Lys Glu Trp Ala Lys Ser Thr Gly Tyr Asp Pro Val Lys Leu Phe Thr 
                245                 250                 255     


Lys Leu Phe Lys Asp Asp Ile Arg Tyr Leu Leu Thr Met Asp Lys Leu 
            260                 265                 270         


Trp Arg Lys Arg Lys Pro Pro Val Pro Leu Asp Trp Ala Glu Val Gln 
        275                 280                 285             


Ser Gln Gly Glu Glu Thr Asn Ala Ser Asp Gln Gln Asn Glu Pro Gln 
    290                 295                 300                 


Leu Gly Leu Lys Asp Gln Gln Val Leu Asp Val Lys Ser Tyr Ala Arg 
305                 310                 315                 320 


Leu Phe Ser Lys Ser Ile Glu Thr Leu Arg Val His Leu Ala Glu Lys 
                325                 330                 335     


Gly Asp Gly Ala Glu Leu Ile Trp Asp Lys Asp Asp Pro Ser Ala Met 
            340                 345                 350         


Asp Phe Val Thr Ser Ala Ala Asn Leu Arg Met His Ile Phe Ser Met 
        355                 360                 365             


Asn Met Lys Ser Arg Phe Asp Ile Lys Ser Met Ala Gly Asn Ile Ile 
    370                 375                 380                 


Pro Ala Ile Ala Thr Thr Asn Ala Val Ile Ala Gly Leu Ile Val Leu 
385                 390                 395                 400 


Glu Gly Leu Lys Ile Leu Ser Gly Lys Ile Asp Gln Cys Arg Thr Ile 
                405                 410                 415     


Phe Leu Asn Lys Gln Pro Asn Pro Arg Lys Lys Leu Leu Val Pro Cys 
            420                 425                 430         


Ala Leu Asp Pro Pro Asn Pro Asn Cys Tyr Val Cys Ala Ser Lys Pro 
        435                 440                 445             


Glu Val Thr Val Arg Leu Asn Val His Lys Val Thr Val Leu Thr Leu 
    450                 455                 460                 


Gln Asp Lys Ile Val Lys Glu Lys Phe Ala Met Val Ala Pro Asp Val 
465                 470                 475                 480 


Gln Ile Glu Asp Gly Lys Gly Thr Ile Leu Ile Ser Ser Glu Glu Gly 
                485                 490                 495     


Glu Thr Glu Ala Asn Asn His Lys Lys Leu Ser Glu Phe Gly Ile Arg 
            500                 505                 510         


Asn Gly Ser Arg Leu Gln Ala Asp Asp Phe Leu Gln Asp Tyr Thr Leu 
        515                 520                 525             


Leu Ile Asn Ile Leu His Ser Glu Asp Leu Gly Lys Asp Val Glu Phe 
    530                 535                 540                 


Glu Val Val Gly Asp Ala Pro Glu Lys Val Gly Pro Lys Gln Ala Glu 
545                 550                 555                 560 


Asp Ala Ala Lys Ser Ile Thr Asn Gly Ser Asp Asp Gly Ala Gln Pro 
                565                 570                 575     


Ser Thr Ser Thr Ala Gln Glu Gln Asp Asp Val Leu Ile Val Asp Ser 
            580                 585                 590         


Asp Glu Glu Asp Ser Ser Asn Asn Ala Asp Val Ser Glu Glu Glu Arg 
        595                 600                 605             


Ser Arg Lys Arg Lys Leu Asp Glu Lys Glu Asn Leu Ser Ala Lys Arg 
    610                 615                 620                 


Ser Arg Ile Glu Gln Lys Glu Glu Leu Asp Asp Val Ile Ala Leu Asp 
625                 630                 635                 640 


<210> 847
<211> 463
<212> PRT
<213> Homo sapiens

<400> 847
Met Ala Asp Gly Glu Glu Pro Glu Lys Lys Arg Arg Arg Ile Glu Glu 
1               5                   10                  15      


Leu Leu Ala Glu Lys Met Ala Val Asp Gly Gly Cys Gly Asp Thr Gly 
            20                  25                  30          


Asp Trp Glu Gly Arg Trp Asn His Val Lys Lys Phe Leu Glu Arg Ser 
        35                  40                  45              


Gly Pro Phe Thr His Pro Asp Phe Glu Pro Ser Thr Glu Ser Leu Gln 
    50                  55                  60                  


Phe Leu Leu Asp Thr Cys Lys Val Leu Val Ile Gly Ala Gly Gly Leu 
65                  70                  75                  80  


Gly Cys Glu Leu Leu Lys Asn Leu Ala Leu Ser Gly Phe Arg Gln Ile 
                85                  90                  95      


His Val Ile Asp Met Asp Thr Ile Asp Val Ser Asn Leu Asn Arg Gln 
            100                 105                 110         


Phe Leu Phe Arg Pro Lys Asp Ile Gly Arg Pro Lys Ala Glu Val Ala 
        115                 120                 125             


Ala Glu Phe Leu Asn Asp Arg Val Pro Asn Cys Asn Val Val Pro His 
    130                 135                 140                 


Phe Asn Lys Ile Gln Asp Phe Asn Asp Thr Phe Tyr Arg Gln Phe His 
145                 150                 155                 160 


Ile Ile Val Cys Gly Leu Asp Ser Ile Ile Ala Arg Arg Trp Ile Asn 
                165                 170                 175     


Gly Met Leu Ile Ser Leu Leu Asn Tyr Glu Asp Gly Val Leu Asp Pro 
            180                 185                 190         


Ser Ser Ile Val Pro Leu Ile Asp Gly Gly Thr Glu Gly Phe Lys Gly 
        195                 200                 205             


Asn Ala Arg Val Ile Leu Pro Gly Met Thr Ala Cys Ile Glu Cys Thr 
    210                 215                 220                 


Leu Glu Leu Tyr Pro Pro Gln Val Asn Phe Pro Met Cys Thr Ile Ala 
225                 230                 235                 240 


Ser Met Pro Arg Leu Pro Glu His Cys Ile Glu Tyr Val Arg Met Leu 
                245                 250                 255     


Gln Trp Pro Lys Glu Gln Pro Phe Gly Glu Gly Val Pro Leu Asp Gly 
            260                 265                 270         


Asp Asp Pro Glu His Ile Gln Trp Ile Phe Gln Lys Ser Leu Glu Arg 
        275                 280                 285             


Ala Ser Gln Tyr Asn Ile Arg Gly Val Thr Tyr Arg Leu Thr Gln Gly 
    290                 295                 300                 


Val Val Lys Arg Ile Ile Pro Ala Val Ala Ser Thr Asn Ala Val Ile 
305                 310                 315                 320 


Ala Ala Val Cys Ala Thr Glu Val Phe Lys Ile Ala Thr Ser Ala Tyr 
                325                 330                 335     


Ile Pro Leu Asn Asn Tyr Leu Val Phe Asn Asp Val Asp Gly Leu Tyr 
            340                 345                 350         


Thr Tyr Thr Phe Glu Ala Glu Arg Lys Glu Asn Cys Pro Ala Cys Ser 
        355                 360                 365             


Gln Leu Pro Gln Asn Ile Gln Phe Ser Pro Ser Ala Lys Leu Gln Glu 
    370                 375                 380                 


Val Leu Asp Tyr Leu Thr Asn Ser Ala Ser Leu Gln Met Lys Ser Pro 
385                 390                 395                 400 


Ala Ile Thr Ala Thr Leu Glu Gly Lys Asn Arg Thr Leu Tyr Leu Gln 
                405                 410                 415     


Ser Val Thr Ser Ile Glu Glu Arg Thr Arg Pro Asn Leu Ser Lys Thr 
            420                 425                 430         


Leu Lys Glu Leu Gly Leu Val Asp Gly Gln Glu Leu Ala Val Ala Asp 
        435                 440                 445             


Val Thr Thr Pro Gln Thr Val Leu Phe Lys Leu His Phe Thr Ser 
    450                 455                 460             


<210> 848
<211> 1052
<212> PRT
<213> Homo sapiens

<400> 848
Met Glu Gly Ser Glu Pro Val Ala Ala His Gln Gly Glu Glu Ala Ser 
1               5                   10                  15      


Cys Ser Ser Trp Gly Thr Gly Ser Thr Asn Lys Asn Leu Pro Ile Met 
            20                  25                  30          


Ser Thr Ala Ser Val Glu Ile Asp Asp Ala Leu Tyr Ser Arg Gln Arg 
        35                  40                  45              


Tyr Val Leu Gly Asp Thr Ala Met Gln Lys Met Ala Lys Ser His Val 
    50                  55                  60                  


Phe Leu Ser Gly Met Gly Gly Leu Gly Leu Glu Ile Ala Lys Asn Leu 
65                  70                  75                  80  


Val Leu Ala Gly Ile Lys Ala Val Thr Ile His Asp Thr Glu Lys Cys 
                85                  90                  95      


Gln Ala Trp Asp Leu Gly Thr Asn Phe Phe Leu Ser Glu Asp Asp Val 
            100                 105                 110         


Val Asn Lys Arg Asn Arg Ala Glu Ala Val Leu Lys His Ile Ala Glu 
        115                 120                 125             


Leu Asn Pro Tyr Val His Val Thr Ser Ser Ser Val Pro Phe Asn Glu 
    130                 135                 140                 


Thr Thr Asp Leu Ser Phe Leu Asp Lys Tyr Gln Cys Val Val Leu Thr 
145                 150                 155                 160 


Glu Met Lys Leu Pro Leu Gln Lys Lys Ile Asn Asp Phe Cys Arg Ser 
                165                 170                 175     


Gln Cys Pro Pro Ile Lys Phe Ile Ser Ala Asp Val His Gly Ile Trp 
            180                 185                 190         


Ser Arg Leu Phe Cys Asp Phe Gly Asp Glu Phe Glu Val Leu Asp Thr 
        195                 200                 205             


Thr Gly Glu Glu Pro Lys Glu Ile Phe Ile Ser Asn Ile Thr Gln Ala 
    210                 215                 220                 


Asn Pro Gly Ile Val Thr Cys Leu Glu Asn His Pro His Lys Leu Glu 
225                 230                 235                 240 


Thr Gly Gln Phe Leu Thr Phe Arg Glu Ile Asn Gly Met Thr Gly Leu 
                245                 250                 255     


Asn Gly Ser Ile Gln Gln Ile Thr Val Ile Ser Pro Phe Ser Phe Ser 
            260                 265                 270         


Ile Gly Asp Thr Thr Glu Leu Glu Pro Tyr Leu His Gly Gly Ile Ala 
        275                 280                 285             


Val Gln Val Lys Thr Pro Lys Thr Val Phe Phe Glu Ser Leu Glu Arg 
    290                 295                 300                 


Gln Leu Lys His Pro Lys Cys Leu Ile Val Asp Phe Ser Asn Pro Glu 
305                 310                 315                 320 


Ala Pro Leu Glu Ile His Thr Ala Met Leu Ala Leu Asp Gln Phe Gln 
                325                 330                 335     


Glu Lys Tyr Ser Arg Lys Pro Asn Val Gly Cys Gln Gln Asp Ser Glu 
            340                 345                 350         


Glu Leu Leu Lys Leu Ala Thr Ser Ile Ser Glu Thr Leu Glu Glu Lys 
        355                 360                 365             


Pro Asp Val Asn Ala Asp Ile Val His Trp Leu Ser Trp Thr Ala Gln 
    370                 375                 380                 


Gly Phe Leu Ser Pro Leu Ala Ala Ala Val Gly Gly Val Ala Ser Gln 
385                 390                 395                 400 


Glu Val Leu Lys Ala Val Thr Gly Lys Phe Ser Pro Leu Cys Gln Trp 
                405                 410                 415     


Leu Tyr Leu Glu Ala Ala Asp Ile Val Glu Ser Leu Gly Lys Pro Glu 
            420                 425                 430         


Cys Glu Glu Phe Leu Pro Arg Gly Asp Arg Tyr Asp Ala Leu Arg Ala 
        435                 440                 445             


Cys Ile Gly Asp Thr Leu Cys Gln Lys Leu Gln Asn Leu Asn Ile Phe 
    450                 455                 460                 


Leu Val Gly Cys Gly Ala Ile Gly Cys Glu Met Leu Lys Asn Phe Ala 
465                 470                 475                 480 


Leu Leu Gly Val Gly Thr Ser Lys Glu Lys Gly Met Ile Thr Val Thr 
                485                 490                 495     


Asp Pro Asp Leu Ile Glu Lys Ser Asn Leu Asn Arg Gln Phe Leu Phe 
            500                 505                 510         


Arg Pro His His Ile Gln Lys Pro Lys Ser Tyr Thr Ala Ala Asp Ala 
        515                 520                 525             


Thr Leu Lys Ile Asn Ser Gln Ile Lys Ile Asp Ala His Leu Asn Lys 
    530                 535                 540                 


Val Cys Pro Thr Thr Glu Thr Ile Tyr Asn Asp Glu Phe Tyr Thr Lys 
545                 550                 555                 560 


Gln Asp Val Ile Ile Thr Ala Leu Asp Asn Val Glu Ala Arg Arg Tyr 
                565                 570                 575     


Val Asp Ser Arg Cys Leu Ala Asn Leu Arg Pro Leu Leu Asp Ser Gly 
            580                 585                 590         


Thr Met Gly Thr Lys Gly His Thr Glu Val Ile Val Pro His Leu Thr 
        595                 600                 605             


Glu Ser Tyr Asn Ser His Arg Asp Pro Pro Glu Glu Glu Ile Pro Phe 
    610                 615                 620                 


Cys Thr Leu Lys Ser Phe Pro Ala Ala Ile Glu His Thr Ile Gln Trp 
625                 630                 635                 640 


Ala Arg Asp Lys Phe Glu Ser Ser Phe Ser His Lys Pro Ser Leu Phe 
                645                 650                 655     


Asn Lys Phe Trp Gln Thr Tyr Ser Ser Ala Glu Glu Val Leu Gln Lys 
            660                 665                 670         


Ile Gln Ser Gly His Ser Leu Glu Gly Cys Phe Gln Val Ile Lys Leu 
        675                 680                 685             


Leu Ser Arg Arg Pro Arg Asn Trp Ser Gln Cys Val Glu Leu Ala Arg 
    690                 695                 700                 


Leu Lys Phe Glu Lys Tyr Phe Asn His Lys Ala Leu Gln Leu Leu His 
705                 710                 715                 720 


Cys Phe Pro Leu Asp Ile Arg Leu Lys Asp Gly Ser Leu Phe Trp Gln 
                725                 730                 735     


Ser Pro Lys Arg Pro Pro Ser Pro Ile Lys Phe Asp Leu Asn Glu Pro 
            740                 745                 750         


Leu His Leu Ser Phe Leu Gln Asn Ala Ala Lys Leu Tyr Ala Thr Val 
        755                 760                 765             


Tyr Cys Ile Pro Phe Ala Glu Glu Asp Leu Ser Ala Asp Ala Leu Leu 
    770                 775                 780                 


Asn Ile Leu Ser Glu Val Lys Ile Gln Glu Phe Lys Pro Ser Asn Lys 
785                 790                 795                 800 


Val Val Gln Thr Asp Glu Thr Ala Arg Lys Pro Asp His Val Pro Ile 
                805                 810                 815     


Ser Ser Glu Asp Glu Arg Asn Ala Ile Phe Gln Leu Glu Lys Ala Ile 
            820                 825                 830         


Leu Ser Asn Glu Ala Thr Lys Ser Asp Leu Gln Met Ala Val Leu Ser 
        835                 840                 845             


Phe Glu Lys Asp Asp Asp His Asn Gly His Ile Asp Phe Ile Thr Ala 
    850                 855                 860                 


Ala Ser Asn Leu Arg Ala Lys Met Tyr Ser Ile Glu Pro Ala Asp Arg 
865                 870                 875                 880 


Phe Lys Thr Lys Arg Ile Ala Gly Lys Ile Ile Pro Ala Ile Ala Thr 
                885                 890                 895     


Thr Thr Ala Thr Val Ser Gly Leu Val Ala Leu Glu Met Ile Lys Val 
            900                 905                 910         


Thr Gly Gly Tyr Pro Phe Glu Ala Tyr Lys Asn Cys Phe Leu Asn Leu 
        915                 920                 925             


Ala Ile Pro Ile Val Val Phe Thr Glu Thr Thr Glu Val Arg Lys Thr 
    930                 935                 940                 


Lys Ile Arg Asn Gly Ile Ser Phe Thr Ile Trp Asp Arg Trp Thr Val 
945                 950                 955                 960 


His Gly Lys Glu Asp Phe Thr Leu Leu Asp Phe Ile Asn Ala Val Lys 
                965                 970                 975     


Glu Lys Tyr Gly Ile Glu Pro Thr Met Val Val Gln Gly Val Lys Met 
            980                 985                 990         


Leu Tyr Val Pro Val Met Pro Gly  His Ala Lys Arg Leu  Lys Leu Thr 
        995                 1000                 1005             


Met His  Lys Leu Val Lys Pro  Thr Thr Glu Lys Lys  Tyr Val Asp 
    1010                 1015                 1020             


Leu Thr  Val Ser Phe Ala Pro  Asp Ile Asp Gly Asp  Glu Asp Leu 
    1025                 1030                 1035             


Pro Gly  Pro Pro Val Arg Tyr  Tyr Phe Ser His Asp  Thr Asp 
    1040                 1045                 1050         


<210> 849
<211> 1012
<212> PRT
<213> Schizosaccharomyces pombe

<400> 849
Met Ser Asn Asn Met Asn Ile Asp Gln Thr Asp Gln Asn Thr Ile Asp 
1               5                   10                  15      


Glu Gly Leu Tyr Ser Arg Gln Leu Tyr Val Leu Gly His Glu Ala Met 
            20                  25                  30          


Lys Gln Met Ser Gln Ser Asn Val Leu Ile Ile Gly Cys Lys Gly Leu 
        35                  40                  45              


Gly Val Glu Ile Ala Lys Asn Val Cys Leu Ala Gly Val Lys Ser Val 
    50                  55                  60                  


Thr Leu Tyr Asp Pro Gln Pro Thr Arg Ile Glu Asp Leu Ser Ser Gln 
65                  70                  75                  80  


Tyr Phe Leu Thr Glu Asp Asp Ile Gly Val Pro Arg Ala Lys Val Thr 
                85                  90                  95      


Val Ser Lys Leu Ala Glu Leu Asn Gln Tyr Val Pro Val Ser Val Val 
            100                 105                 110         


Asp Glu Leu Ser Thr Glu Tyr Leu Lys Asn Phe Lys Cys Val Val Val 
        115                 120                 125             


Thr Glu Thr Ser Leu Thr Lys Gln Leu Glu Ile Asn Asp Phe Thr His 
    130                 135                 140                 


Lys Asn His Ile Ala Tyr Ile Ala Ala Asp Ser Arg Gly Leu Phe Gly 
145                 150                 155                 160 


Ser Ile Phe Cys Asp Phe Gly Glu Asn Phe Ile Cys Thr Asp Thr Asp 
                165                 170                 175     


Gly Asn Glu Pro Leu Thr Gly Met Ile Ala Ser Ile Thr Asp Asp Gly 
            180                 185                 190         


Val Val Thr Met Leu Glu Glu Thr Arg His Gly Leu Glu Asn Gly Asp 
        195                 200                 205             


Phe Val Lys Phe Thr Glu Val Lys Gly Met Pro Gly Leu Asn Asp Gly 
    210                 215                 220                 


Thr Pro Arg Lys Val Glu Val Lys Gly Pro Tyr Thr Phe Ser Ile Gly 
225                 230                 235                 240 


Ser Val Lys Asp Leu Gly Ser Ala Gly Tyr Asn Gly Val Phe Thr Gln 
                245                 250                 255     


Val Lys Val Pro Thr Lys Ile Ser Phe Lys Ser Leu Arg Glu Ser Leu 
            260                 265                 270         


Lys Asp Pro Glu Tyr Val Tyr Pro Asp Phe Gly Lys Met Met Arg Pro 
        275                 280                 285             


Pro Gln Tyr His Ile Ala Phe Gln Ala Leu Ser Ala Phe Ala Asp Ala 
    290                 295                 300                 


His Glu Gly Ser Leu Pro Arg Pro Arg Asn Asp Ile Asp Ala Ala Glu 
305                 310                 315                 320 


Phe Phe Glu Phe Cys Lys Lys Ile Ala Ser Thr Leu Gln Phe Asp Val 
                325                 330                 335     


Glu Leu Asp Glu Lys Leu Ile Lys Glu Ile Ser Tyr Gln Ala Arg Gly 
            340                 345                 350         


Asp Leu Val Ala Met Ser Ala Phe Leu Gly Gly Ala Val Ala Gln Glu 
        355                 360                 365             


Val Leu Lys Ala Thr Thr Ser Lys Phe Tyr Pro Leu Lys Gln Tyr Phe 
    370                 375                 380                 


Tyr Phe Asp Ser Leu Glu Ser Leu Pro Ser Ser Val Thr Ile Ser Glu 
385                 390                 395                 400 


Glu Thr Cys Lys Pro Arg Gly Cys Arg Tyr Asp Gly Gln Ile Ala Val 
                405                 410                 415     


Phe Gly Ser Glu Phe Gln Glu Lys Ile Ala Ser Leu Ser Thr Phe Leu 
            420                 425                 430         


Val Gly Ala Gly Ala Ile Gly Cys Glu Met Leu Lys Asn Trp Ala Met 
        435                 440                 445             


Met Gly Val Ala Thr Gly Glu Ser Gly His Ile Ser Val Thr Asp Met 
    450                 455                 460                 


Asp Ser Ile Glu Lys Ser Asn Leu Asn Arg Gln Phe Leu Phe Arg Pro 
465                 470                 475                 480 


Arg Asp Val Gly Lys Leu Lys Ser Glu Cys Ala Ser Thr Ala Val Ser 
                485                 490                 495     


Ile Met Asn Pro Ser Leu Thr Gly Lys Ile Thr Ser Tyr Gln Glu Arg 
            500                 505                 510         


Val Gly Pro Glu Ser Glu Gly Ile Phe Gly Asp Glu Phe Phe Glu Lys 
        515                 520                 525             


Leu Ser Leu Val Thr Asn Ala Leu Asp Asn Val Glu Ala Arg Met Tyr 
    530                 535                 540                 


Val Asp Arg Arg Cys Val Phe Phe Glu Lys Pro Leu Leu Glu Ser Gly 
545                 550                 555                 560 


Thr Leu Gly Thr Lys Gly Asn Thr Gln Val Val Val Pro His Leu Thr 
                565                 570                 575     


Glu Ser Tyr Gly Ser Ser Gln Asp Pro Pro Glu Lys Ser Phe Pro Ile 
            580                 585                 590         


Cys Thr Leu Lys Asn Phe Pro Asn Arg Ile Glu His Thr Ile Ala Trp 
        595                 600                 605             


Ala Arg Asp Leu Phe Glu Gly Leu Phe Lys Gln Pro Ile Asp Asn Val 
    610                 615                 620                 


Asn Met Tyr Leu Ser Ser Pro Asn Phe Leu Glu Thr Ser Leu Lys Thr 
625                 630                 635                 640 


Ser Ser Asn Pro Arg Glu Val Leu Glu Asn Ile Arg Asp Tyr Leu Val 
                645                 650                 655     


Thr Glu Lys Pro Leu Ser Phe Glu Glu Cys Ile Met Trp Ala Arg Leu 
            660                 665                 670         


Gln Phe Asp Lys Phe Phe Asn Asn Asn Ile Gln Gln Leu Leu Phe Asn 
        675                 680                 685             


Phe Pro Lys Asp Ser Val Thr Ser Thr Gly Gln Pro Phe Trp Ser Gly 
    690                 695                 700                 


Pro Lys Arg Ala Pro Thr Pro Leu Ser Phe Asp Ile His Asn Arg Glu 
705                 710                 715                 720 


His Phe Asp Phe Ile Val Ala Ala Ala Ser Leu Tyr Ala Phe Asn Tyr 
                725                 730                 735     


Gly Leu Lys Ser Glu Thr Asp Pro Ala Ile Tyr Glu Arg Val Leu Ala 
            740                 745                 750         


Gly Tyr Asn Pro Pro Pro Phe Ala Pro Lys Ser Gly Ile Lys Ile Gln 
        755                 760                 765             


Val Asn Glu Asn Glu Glu Ala Pro Glu Thr Ala Ala Asn Lys Asp Lys 
    770                 775                 780                 


Gln Glu Leu Lys Ser Ile Ala Asp Ser Leu Pro Pro Pro Ser Ser Leu 
785                 790                 795                 800 


Val Gly Phe Arg Leu Thr Pro Ala Glu Phe Glu Lys Asp Asp Asp Ser 
                805                 810                 815     


Asn His His Ile Asp Phe Ile Thr Ala Ala Ser Asn Leu Arg Ala Met 
            820                 825                 830         


Asn Tyr Asp Ile Thr Pro Ala Asp Arg Phe Lys Thr Lys Phe Val Ala 
        835                 840                 845             


Gly Lys Ile Val Pro Ala Met Cys Thr Ser Thr Ala Val Val Ser Gly 
    850                 855                 860                 


Leu Val Cys Leu Glu Leu Val Lys Leu Val Asp Gly Lys Lys Lys Ile 
865                 870                 875                 880 


Glu Glu Tyr Lys Asn Gly Phe Phe Asn Leu Ala Ile Gly Leu Phe Thr 
                885                 890                 895     


Phe Ser Asp Pro Ile Ala Ser Pro Lys Met Lys Val Asn Gly Lys Glu 
            900                 905                 910         


Ile Asp Lys Ile Trp Asp Arg Tyr Asn Leu Pro Asp Cys Thr Leu Gln 
        915                 920                 925             


Glu Leu Ile Asp Tyr Phe Gln Lys Glu Glu Gly Leu Glu Val Thr Met 
    930                 935                 940                 


Leu Ser Ser Gly Val Ser Leu Leu Tyr Ala Asn Phe Gln Pro Pro Lys 
945                 950                 955                 960 


Lys Leu Ala Glu Arg Leu Pro Leu Lys Ile Ser Glu Leu Val Glu Gln 
                965                 970                 975     


Ile Thr Lys Lys Lys Leu Glu Pro Phe Arg Lys His Leu Val Leu Glu 
            980                 985                 990         


Ile Cys Cys Asp Asp Ala Asn Gly  Glu Asp Val Glu Val  Pro Phe Ile 
        995                 1000                 1005             


Cys Ile  Lys Leu 
    1010         


<210> 850
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any non-natural amino acid which can be covalently joined
      "stapled together") using a ring-closing metathesis (RCM)
      reaction to form a cross-linked ring

<400> 850
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 851
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 851
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 852
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 852
Xaa Ser Thr Pro Xaa Arg Glu Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 853
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> S-pentenyl alanine 

<400> 853
Xaa Ser Ser Pro Ser Pro Gly Xaa Arg Arg Xaa Leu Arg Asp Xaa Val 
1               5                   10                  15      


Lys 
    


<210> 854
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> S-pentenyl alanine 

<400> 854
Xaa Ala Leu Lys Arg Ile His Xaa Glu Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


<210> 855
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 855
Met Ala Asn Ile 
1               


<210> 856
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 856
Val Gln Arg Ile Lys Arg 
1               5       


<210> 857
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 857
Phe Lys Glu Val Leu Lys Ser 
1               5           


<210> 858
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 858
Met Ala Asn Ile Ala Val Gln 
1               5           


<210> 859
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 859
Ile Ala Val Gln 
1               


<210> 860
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 860
Leu Asn Lys Asn 
1               


<210> 861
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 861
Met Ala Asn Ile Ala Val Gln Arg Ile Lys 
1               5                   10  


<210> 862
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 862
Ile Ala Val Gln Arg Ile Lys 
1               5           


<210> 863
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 863
Val Leu Lys Ser 
1               


<210> 864
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 864
Met Ala Asn Ile Ala Val Gln Arg Ile Lys Arg 
1               5                   10      


<210> 865
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 865
Ile Ala Val Gln Arg Ile Lys Arg 
1               5               


<210> 866
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 866
Ala Val Gln Arg Ile Lys 
1               5       


<210> 867
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 867
Glu Phe Lys Glu Val Leu Lys Ser 
1               5               


<210> 868
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 868
Met Ala Asn Ile Ala Val 
1               5       


<210> 869
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 869
Arg Ile Lys Arg Glu Phe 
1               5       


<210> 870
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 870
Glu Val Leu Lys Ser 
1               5   


<210> 871
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 871
Met Ser Thr Pro 
1               


<210> 872
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 872
Arg Arg Arg Leu Met Arg 
1               5       


<210> 873
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 873
Phe Lys Arg Leu Gln Glu Asp 
1               5           


<210> 874
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 874
Met Ser Thr Pro Ala Arg Arg 
1               5           


<210> 875
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 875
Pro Ala Arg Arg 
1               


<210> 876
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 876
Met Ser Thr Pro Ala Arg Arg Arg Leu Met 
1               5                   10  


<210> 877
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 877
Pro Ala Arg Arg Arg Leu Met 
1               5           


<210> 878
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 878
Leu Gln Glu Asp 
1               


<210> 879
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 879
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg 
1               5                   10      


<210> 880
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 880
Pro Ala Arg Arg Arg Leu Met Arg 
1               5               


<210> 881
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 881
Ala Arg Arg Arg Leu Met 
1               5       


<210> 882
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 882
Asp Phe Lys Arg Leu Gln Glu Asp 
1               5               


<210> 883
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 883
Met Ser Thr Pro Ala Arg 
1               5       


<210> 884
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 884
Arg Leu Met Arg Asp Phe 
1               5       


<210> 885
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 885
Arg Leu Gln Glu Asp 
1               5   


<210> 886
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 886
Met Thr Glu Leu 
1               


<210> 887
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 887
Ser Ala Leu Leu Leu Arg 
1               5       


<210> 888
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 888
Ile Lys Arg Glu Phe Lys 
1               5       


<210> 889
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 889
Gln Leu Ala Glu Leu Asn Lys Asn 
1               5               


<210> 890
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 890
Met Thr Glu Leu Gln Ser Ala 
1               5           


<210> 891
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 891
Leu Gln Ser Ala 
1               


<210> 892
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 892
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu 
1               5                   10  


<210> 893
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 893
Leu Gln Ser Ala Leu Leu Leu 
1               5           


<210> 894
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 894
Glu Leu Asn Lys Asn 
1               5   


<210> 895
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 895
Met Thr Glu Leu Gln Ser Ala Leu Leu Leu Arg 
1               5                   10      


<210> 896
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 896
Leu Gln Ser Ala Leu Leu Leu Arg 
1               5               


<210> 897
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 897
Gln Ser Ala Leu Leu Leu 
1               5       


<210> 898
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 898
Arg Gln Leu Ala Glu Leu Asn Lys Asn 
1               5                   


<210> 899
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 899
Leu Met Arg Asp Phe Lys 
1               5       


<210> 900
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 900
Met Thr Glu Leu Gln Ser 
1               5       


<210> 901
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 901
Leu Leu Leu Arg Arg Gln 
1               5       


<210> 902
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 902
Ala Glu Leu Asn Lys Asn 
1               5       


<210> 903
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 903
Met Ala Gly Thr 
1               


<210> 904
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 904
Leu Leu Arg Arg Gln Leu 
1               5       


<210> 905
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 905
Leu Lys Arg Leu Met Ala 
1               5       


<210> 906
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 906
Tyr Lys Gln Leu Thr Leu Asn 
1               5           


<210> 907
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 907
Met Ala Gly Thr Ala Leu Lys 
1               5           


<210> 908
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 908
Thr Ala Leu Lys 
1               


<210> 909
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 909
Met Ala Gly Thr Ala Leu Lys Arg Leu Met 
1               5                   10  


<210> 910
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 910
Thr Ala Leu Lys Arg Leu Met 
1               5           


<210> 911
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 911
Leu Thr Leu Asn 
1               


<210> 912
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 912
Met Ala Gly Thr Ala Leu Lys Arg Leu Met Ala 
1               5                   10      


<210> 913
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 913
Thr Ala Leu Lys Arg Leu Met Ala 
1               5               


<210> 914
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 914
Ala Leu Lys Arg Leu Met 
1               5       


<210> 915
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 915
Glu Tyr Lys Gln Leu Thr Leu Asn 
1               5               


<210> 916
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 916
Met Ala Gly Thr Ala Leu 
1               5       


<210> 917
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 917
Arg Leu Met Ala Glu Tyr 
1               5       


<210> 918
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 918
Gln Leu Thr Leu Asn 
1               5   


<210> 919
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 919
Met Ala Arg Pro Leu Val Pro Ser 
1               5               


<210> 920
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 920
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys 
1               5                   10      


<210> 921
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 921
Ser Ser Gln Lys 
1               


<210> 922
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 922
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Leu 
1               5                   10                  


<210> 923
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 923
Ser Ser Gln Lys Ala Leu Leu 
1               5           


<210> 924
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 924
Met Ala Arg Pro Leu Val Pro Ser Ser Gln Lys Ala Leu Leu Leu 
1               5                   10                  15  


<210> 925
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 925
Ser Ser Gln Lys Ala Leu Leu Leu 
1               5               


<210> 926
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 926
Met Ala Arg Pro Leu Val Pro 
1               5           


<210> 927
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 927
Leu Met Ala Glu Tyr Lys 
1               5       


<210> 928
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 928
Gln Lys Ala Leu Leu Leu 
1               5       


<210> 929
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 929
Ser Gln Lys Ala Leu Leu 
1               5       


<210> 930
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 930
Leu Leu Leu Glu Leu Lys 
1               5       


<210> 931
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 931
Leu Lys Gly Leu Gln Glu Glu 
1               5           


<210> 932
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 932
Leu Gln Glu Glu 
1               


<210> 933
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 933
Glu Leu Lys Gly Leu Gln Glu Glu 
1               5               


<210> 934
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 934
Leu Met Leu Glu Leu Lys 
1               5       


<210> 935
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 935
Met Ala Gln Gln Gln Met Thr Ser 
1               5               


<210> 936
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 936
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys 
1               5                   10      


<210> 937
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 937
Ser Ser Gln Lys 
1               


<210> 938
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 938
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Met 
1               5                   10                  


<210> 939
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 939
Ser Ser Gln Lys Ala Leu Met 
1               5           


<210> 940
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 940
Met Ala Gln Gln Gln Met Thr Ser Ser Gln Lys Ala Leu Met Leu 
1               5                   10                  15  


<210> 941
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 941
Ser Ser Gln Lys Ala Leu Met Leu 
1               5               


<210> 942
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 942
Met Ala Gln Gln Gln Met Thr 
1               5           


<210> 943
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 943
Ile Gln Lys Glu Leu Ser 
1               5       


<210> 944
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 944
Gln Lys Ala Leu Met Leu 
1               5       


<210> 945
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 945
Ser Gln Lys Ala Leu Met 
1               5       


<210> 946
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 946
Ile His Lys Glu Leu Asn 
1               5       


<210> 947
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 947
Leu Lys Ser Leu Gln Glu Glu 
1               5           


<210> 948
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 948
Ala Tyr Leu Leu 
1               


<210> 949
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 949
Glu Leu Lys Ser Leu Gln Glu Glu 
1               5               


<210> 950
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 950
Ile Asn Lys Glu Leu Ser 
1               5       


<210> 951
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 951
Met Ala Leu Lys 
1               


<210> 952
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 952
Met Ala Leu Lys Arg Ile Gln 
1               5           


<210> 953
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 953
Met Ala Leu Lys Arg Ile Gln Lys 
1               5               


<210> 954
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 954
Leu Lys Arg Ile Gln Lys 
1               5       


<210> 955
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 955
Ala Leu Lys Arg Ile Gln 
1               5       


<210> 956
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 956
Arg Ile Gln Lys Glu Leu 
1               5       


<210> 957
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 957
Leu Ser Asp Leu Gln Arg Asp 
1               5           


<210> 958
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 958
Leu Gln Arg Asp 
1               


<210> 959
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 959
Glu Leu Ser Asp Leu Gln Arg Asp 
1               5               


<210> 960
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 960
Asp Leu Gln Arg Asp 
1               5   


<210> 961
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 961
Glu Ile Gln Lys Asn 
1               5   


<210> 962
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 962
Met Ala Leu Lys Arg Ile His 
1               5           


<210> 963
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 963
Met Ala Leu Lys Arg Ile His Lys 
1               5               


<210> 964
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 964
Leu Lys Arg Ile His Lys 
1               5       


<210> 965
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 965
Ala Leu Lys Arg Ile His 
1               5       


<210> 966
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 966
Arg Ile His Lys Glu Leu 
1               5       


<210> 967
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 967
Leu Asn Asp Leu Ala Arg Asp 
1               5           


<210> 968
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 968
Leu Ala Arg Asp 
1               


<210> 969
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 969
Glu Leu Asn Asp Leu Ala Arg Asp 
1               5               


<210> 970
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 970
Asp Leu Ala Arg Asp 
1               5   


<210> 971
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 971
Leu Leu Arg Lys Gln Leu 
1               5       


<210> 972
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 972
Met Ala Leu Lys Arg Ile Asn 
1               5           


<210> 973
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 973
Met Ala Leu Lys Arg Ile Asn Lys 
1               5               


<210> 974
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 974
Leu Lys Arg Ile Asn Lys 
1               5       


<210> 975
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 975
Ala Leu Lys Arg Ile Asn 
1               5       


<210> 976
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 976
Arg Ile Asn Lys Glu Leu 
1               5       


<210> 977
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 977
Leu Ser Asp Leu Ala Arg Asp 
1               5           


<210> 978
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 978
Leu Ala Arg Asp 
1               


<210> 979
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 979
Glu Leu Ser Asp Leu Ala Arg Asp 
1               5               


<210> 980
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 980
Asp Leu Ala Arg Asp 
1               5   


<210> 981
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 981
Met Pro Ser Ser Ala Ser Arg 
1               5           


<210> 982
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 982
Met Pro Ser Ser Ala Ser Glu 
1               5           


<210> 983
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 983
Gln Leu Lys Glu Ile Gln 
1               5       


<210> 984
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 984
Gln Leu Lys Glu Ile Gln Lys Asn 
1               5               


<210> 985
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 985
Ser Glu Gln Leu Leu Arg 
1               5       


<210> 986
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 986
Met Pro Ser Ser 
1               


<210> 987
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 987
Leu Thr Asp Leu Gln Arg Asp 
1               5           


<210> 988
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 988
Ala Ser Arg Gln Leu Leu Arg Lys 
1               5               


<210> 989
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 989
Glu Leu Thr Asp Leu Gln Arg Asp 
1               5               


<210> 990
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 990
Ala Ser Glu Gln Leu Leu Arg Lys 
1               5               


<210> 991
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 991
Lys Asn Ser Lys Leu Leu Ser Thr 
1               5               


<210> 992
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 992
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys 
1               5                   10      


<210> 993
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 993
Thr Ser Ala Lys 
1               


<210> 994
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 994
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Gln 
1               5                   10                  


<210> 995
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 995
Thr Ser Ala Lys Arg Ile Gln 
1               5           


<210> 996
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 996
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys 
1               5                   10                  15  


<210> 997
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 997
Thr Ser Ala Lys Arg Ile Gln Lys 
1               5               


<210> 998
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 998
Lys Asn Ser Lys Leu Leu Ser 
1               5           


<210> 999
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 999
Lys Asn Ser Lys Leu Leu Ser Thr Ser Ala 
1               5                   10  


<210> 1000
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1000
Ala Lys Arg Ile Gln Lys 
1               5       


<210> 1001
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1001
Ser Ala Lys Arg Ile Gln 
1               5       


<210> 1002
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1002
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys 
1               5                   10          


<210> 1003
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1003
Leu Ala Asp Ile Thr Leu Asp 
1               5           


<210> 1004
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1004
Ile Thr Leu Asp 
1               


<210> 1005
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1005
Glu Leu Ala Asp Ile Thr Leu Asp 
1               5               


<210> 1006
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1006
Asp Ile Thr Leu Asp 
1               5   


<210> 1007
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1007
Lys Thr Ala Ala Lys Leu Ser Thr 
1               5               


<210> 1008
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1008
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys 
1               5                   10      


<210> 1009
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1009
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Arg Lys 
1               5                   10          


<210> 1010
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1010
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln 
1               5                   10                  


<210> 1011
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1011
Ile Gln Lys Asn 
1               


<210> 1012
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1012
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys 
1               5                   10                  15  


<210> 1013
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1013
Ala Ser Arg Gln Leu Leu Arg 
1               5           


<210> 1014
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1014
Lys Thr Ala Ala Lys Leu Ser 
1               5           


<210> 1015
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1015
Lys Thr Ala Ala Lys Leu Ser Thr Ser Ala 
1               5                   10  


<210> 1016
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1016
Ala Ser Glu Gln Leu Leu Arg 
1               5           


<210> 1017
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1017
Met Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg 
1               5                   10      


<210> 1018
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1018
Met Pro Ser Ser Ala Ser Glu Gln Leu Leu Arg 
1               5                   10      


<210> 1019
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1019
Leu Ala Glu Ile Thr Leu Asp 
1               5           


<210> 1020
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1020
Leu Lys Glu Ile Gln 
1               5   


<210> 1021
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1021
Glu Leu Ala Glu Ile Thr Leu Asp 
1               5               


<210> 1022
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1022
Glu Ile Thr Leu Asp 
1               5   


<210> 1023
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1023
Lys Thr Thr Ala Lys Leu Ser Thr 
1               5               


<210> 1024
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1024
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys 
1               5                   10      


<210> 1025
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1025
Leu Lys Glu Ile Gln Lys Asn 
1               5           


<210> 1026
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1026
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln 
1               5                   10                  


<210> 1027
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1027
Ala Ser Arg Gln 
1               


<210> 1028
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1028
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala Lys Arg Ile Gln Lys 
1               5                   10                  15  


<210> 1029
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1029
Ala Ser Glu Gln 
1               


<210> 1030
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1030
Lys Thr Thr Ala Lys Leu Ser 
1               5           


<210> 1031
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1031
Lys Thr Thr Ala Lys Leu Ser Thr Ser Ala 
1               5                   10  


<210> 1032
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1032
Met Pro Ser Ser Ala Ser Arg Gln 
1               5               


<210> 1033
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1033
Met Pro Ser Ser Ala Ser Glu Gln 
1               5               


<210> 1034
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1034
Leu Lys Glu Ile Gln 
1               5   


<210> 1035
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1035
Leu Lys Glu Ile Gln Lys Asn 
1               5           


<210> 1036
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1036
Glu Gln Leu Leu Arg Lys 
1               5       


<210> 1037
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1037
Met Pro Ser Ser Ala 
1               5   


<210> 1038
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1038
Ala Gln Glu Arg Lys Ala 
1               5       


<210> 1039
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1039
Met His Gly Arg Ala 
1               5   


<210> 1040
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1040
Met His Gly Arg Ala Tyr Leu Leu 
1               5               


<210> 1041
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1041
Met His Gly Arg Ala Tyr Leu Leu Leu His Arg 
1               5                   10      


<210> 1042
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1042
Ala Tyr Leu Leu Leu His Arg 
1               5           


<210> 1043
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1043
Met His Gly Arg Ala Tyr Leu Leu Leu His Arg Asp 
1               5                   10          


<210> 1044
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1044
Ala Tyr Leu Leu Leu His Arg Asp 
1               5               


<210> 1045
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1045
Met His Gly Arg 
1               


<210> 1046
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1046
Met His Gly Arg Ala Tyr Leu 
1               5           


<210> 1047
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1047
Leu Leu Leu His Arg Asp 
1               5       


<210> 1048
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1048
Tyr Leu Leu Leu His Arg 
1               5       


<210> 1049
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1049
Leu His Arg Asp Phe Cys 
1               5       


<210> 1050
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1050
Cys Asp Leu Lys Glu Asn Asn 
1               5           


<210> 1051
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1051
Lys Glu Asn Asn 
1               


<210> 1052
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1052
Phe Cys Asp Leu Lys Glu Asn Asn 
1               5               


<210> 1053
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1053
Leu Lys Glu Asn Asn 
1               5   


<210> 1054
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1054
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro 
1               5                   10  


<210> 1055
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1055
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys 
1               5                   10              


<210> 1056
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1056
Pro Ala Val Lys 
1               


<210> 1057
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1057
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Met 
1               5                   10                  15      


<210> 1058
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1058
Pro Ala Val Lys Arg Leu Met 
1               5           


<210> 1059
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1059
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val Lys Arg Leu Met 
1               5                   10                  15      


Lys 
    


<210> 1060
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1060
Pro Ala Val Lys Arg Leu Met Lys 
1               5               


<210> 1061
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1061
Met Glu Thr Arg Tyr Asn Leu Lys Ser 
1               5                   


<210> 1062
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1062
Met Glu Thr Arg Tyr Asn Leu Lys Ser Pro Ala Val 
1               5                   10          


<210> 1063
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1063
Val Lys Arg Leu Met Lys 
1               5       


<210> 1064
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1064
Ala Val Lys Arg Leu Met 
1               5       


<210> 1065
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1065
Ile Gln Lys Glu Leu Thr 
1               5       


<210> 1066
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1066
Ile Gln Lys Glu Leu Ala 
1               5       


<210> 1067
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1067
Arg Leu Met Lys Glu Ala 
1               5       


<210> 1068
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1068
Ala Ala Glu Leu Lys Asp Pro 
1               5           


<210> 1069
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1069
Leu Lys Asp Pro 
1               


<210> 1070
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1070
Glu Ala Ala Glu Leu Lys Asp Pro 
1               5               


<210> 1071
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1071
Glu Leu Lys Asp Pro 
1               5   


<210> 1072
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1072
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr 
1               5                   10          


<210> 1073
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1073
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln 
1               5                   10                  15  


<210> 1074
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1074
Thr Ala Thr Gln 
1               


<210> 1075
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1075
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys 
        


<210> 1076
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1076
Thr Ala Thr Gln Arg Leu Lys 
1               5           


<210> 1077
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1077
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr Gln Arg 
1               5                   10                  15      


Leu Lys Gln 
            


<210> 1078
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1078
Thr Ala Thr Gln Arg Leu Lys Gln 
1               5               


<210> 1079
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1079
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr 
1               5                   10      


<210> 1080
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1080
Met Ser Ser Thr Ser Ser Lys Arg Ala Pro Thr Thr Ala Thr 
1               5                   10                  


<210> 1081
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1081
Thr Gln Arg Leu Lys Gln 
1               5       


<210> 1082
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1082
Ala Thr Gln Arg Leu Lys 
1               5       


<210> 1083
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1083
Arg Leu Lys Gln Asp Tyr 
1               5       


<210> 1084
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1084
Tyr Leu Arg Ile Lys Lys Asp 
1               5           


<210> 1085
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1085
Ile Lys Lys Asp 
1               


<210> 1086
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1086
Asp Tyr Leu Arg Ile Lys Lys Asp 
1               5               


<210> 1087
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1087
Arg Ile Lys Lys Asp 
1               5   


<210> 1088
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1088
Met Ala Gly Leu Pro Arg 
1               5       


<210> 1089
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1089
Gly Leu Pro Arg 
1               


<210> 1090
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1090
Met Ala Gly Leu Pro Arg Arg Ile Ile 
1               5                   


<210> 1091
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1091
Gly Leu Pro Arg Arg Ile Ile 
1               5           


<210> 1092
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1092
Met Ala Gly Leu Pro Arg Arg Ile Ile Lys 
1               5                   10  


<210> 1093
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1093
Gly Leu Pro Arg Arg Ile Ile Lys 
1               5               


<210> 1094
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1094
Met Ala Gly Leu Pro 
1               5   


<210> 1095
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1095
Pro Arg Arg Ile Ile Lys Glu 
1               5           


<210> 1096
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1096
Leu Pro Arg Arg Ile Ile 
1               5       


<210> 1097
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1097
Arg Ile Ile Lys Glu Thr 
1               5       


<210> 1098
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1098
Thr Gln Arg Leu Leu Ala Glu 
1               5           


<210> 1099
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1099
Leu Leu Ala Glu 
1               


<210> 1100
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1100
Glu Thr Gln Arg Leu Leu Ala Glu 
1               5               


<210> 1101
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1101
Arg Leu Leu Ala Glu 
1               5   


<210> 1102
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1102
Met Ala Glu Leu Pro His 
1               5       


<210> 1103
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1103
Glu Leu Pro His 
1               


<210> 1104
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1104
Met Ala Glu Leu Pro His Arg Ile Ile 
1               5                   


<210> 1105
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1105
Glu Leu Pro His Arg Ile Ile 
1               5           


<210> 1106
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1106
Met Ala Glu Leu Pro His Arg Ile Ile Lys 
1               5                   10  


<210> 1107
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1107
Glu Leu Pro His Arg Ile Ile Lys 
1               5               


<210> 1108
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1108
Met Ala Glu Leu Pro 
1               5   


<210> 1109
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1109
Pro His Arg Ile Ile Lys 
1               5       


<210> 1110
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1110
Leu Pro His Arg Ile Ile 
1               5       


<210> 1111
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1111
Arg Ile Ile Lys Glu Thr Gln 
1               5           


<210> 1112
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1112
Ala Leu Ser Arg 
1               


<210> 1113
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1113
Leu Arg Ile Gln Lys Asp 
1               5       


<210> 1114
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1114
Lys Lys Ala Ser Ala Ala 
1               5       


<210> 1115
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1115
Asp Lys Leu Leu Val Lys 
1               5       


<210> 1116
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1116
Met Gln Arg Ala Ser 
1               5   


<210> 1117
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1117
Gln Arg Ala Ser 
1               


<210> 1118
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1118
Met Gln Arg Ala Ser Arg Leu Lys 
1               5               


<210> 1119
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1119
Gln Arg Ala Ser Arg Leu Lys 
1               5           


<210> 1120
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1120
Met Gln Arg Ala Ser Arg Leu Lys Arg 
1               5                   


<210> 1121
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1121
Gln Arg Ala Ser Arg Leu Lys Arg 
1               5               


<210> 1122
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1122
Met Gln Arg Ala 
1               


<210> 1123
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1123
Ala Ser Arg Leu Lys Arg 
1               5       


<210> 1124
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1124
Arg Ala Ser Arg Leu Lys 
1               5       


<210> 1125
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1125
Arg Leu Lys Arg Glu Leu 
1               5       


<210> 1126
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1126
Leu His Met Leu Ala Thr Glu 
1               5           


<210> 1127
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1127
Leu Ala Thr Glu 
1               


<210> 1128
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1128
Glu Leu His Met Leu Ala Thr Glu 
1               5               


<210> 1129
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1129
Met Leu Ala Thr Glu 
1               5   


<210> 1130
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1130
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro 
1               5                   10          


<210> 1131
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1131
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe 
1               5                   10                  15  


<210> 1132
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1132
Pro Arg Asn Phe 
1               


<210> 1133
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1133
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu 
        


<210> 1134
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1134
Pro Arg Asn Phe Arg Leu Leu 
1               5           


<210> 1135
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1135
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn Phe Arg 
1               5                   10                  15      


Leu Leu Glu 
            


<210> 1136
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1136
Pro Arg Asn Phe Arg Leu Leu Glu 
1               5               


<210> 1137
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1137
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val 
1               5                   10      


<210> 1138
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1138
Met Ala Ala Thr Thr Gly Ser Gly Val Lys Val Pro Arg Asn 
1               5                   10                  


<210> 1139
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1139
Asn Phe Arg Leu Leu Glu 
1               5       


<210> 1140
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1140
Leu Glu Glu Gly 
1               


<210> 1141
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1141
Arg Asn Phe Arg Leu Leu 
1               5       


<210> 1142
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1142
Arg Leu Leu Glu Glu Leu 
1               5       


<210> 1143
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1143
Leu Glu Glu Gly Gln Lys Gly 
1               5           


<210> 1144
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1144
Gly Gln Lys Gly 
1               


<210> 1145
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1145
Glu Leu Glu Glu Gly Gln Lys Gly 
1               5               


<210> 1146
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1146
Glu Gly Gln Lys Gly 
1               5   


<210> 1147
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1147
Met Ala Val Ser Thr Gly Val Lys Val Pro 
1               5                   10  


<210> 1148
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1148
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe 
1               5                   10              


<210> 1149
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1149
Arg Arg Val Ser Val 
1               5   


<210> 1150
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1150
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


<210> 1151
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1151
Leu Ser Arg Cys 
1               


<210> 1152
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1152
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn Phe Arg Leu Leu 
1               5                   10                  15      


Glu 
    


<210> 1153
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1153
Glu Leu Asn Leu Val Arg 
1               5       


<210> 1154
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1154
Met Ala Val Ser Thr Gly Val Lys Val 
1               5                   


<210> 1155
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1155
Met Ala Val Ser Thr Gly Val Lys Val Pro Arg Asn 
1               5                   10          


<210> 1156
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1156
Gly Ala Val Ser Gly Ser Val Gln Ala Ser 
1               5                   10  


<210> 1157
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1157
Ala Ser Asp Arg Leu Met 
1               5       


<210> 1158
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1158
Gln Ala Ser Asp Arg Leu Met Lys 
1               5               


<210> 1159
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1159
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Met Lys 
1               5                   10                  15  


<210> 1160
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1160
Gln Ala Ser Asp Arg Leu Met 
1               5           


<210> 1161
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1161
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp Arg Leu Met 
1               5                   10                  


<210> 1162
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1162
Gln Ala Ser Asp 
1               


<210> 1163
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1163
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His 
1               5                   10      


<210> 1164
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1164
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg 
1               5                   10                  


<210> 1165
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1165
His Ile Ile Arg 
1               


<210> 1166
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1166
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr 
    


<210> 1167
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1167
His Ile Ile Arg Leu Val Tyr 
1               5           


<210> 1168
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1168
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile Arg Leu Val 
1               5                   10                  15      


Tyr Lys 
        


<210> 1169
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1169
His Ile Ile Arg Leu Val Tyr Lys 
1               5               


<210> 1170
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1170
Met Asn Ser Asn Val Glu Asn Leu Pro Pro 
1               5                   10  


<210> 1171
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1171
Met Asn Ser Asn Val Glu Asn Leu Pro Pro His Ile Ile 
1               5                   10              


<210> 1172
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1172
Ile Arg Leu Val Tyr Lys 
1               5       


<210> 1173
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1173
Ile Ile Arg Leu Val Tyr 
1               5       


<210> 1174
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1174
Leu Val Tyr Lys Glu Val 
1               5       


<210> 1175
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1175
Val Thr Thr Leu Thr Ala Asp 
1               5           


<210> 1176
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1176
Leu Thr Ala Asp 
1               


<210> 1177
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1177
Glu Val Thr Thr Leu Thr Ala Asp 
1               5               


<210> 1178
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1178
Thr Leu Thr Ala Asp 
1               5   


<210> 1179
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1179
Ala Arg Gly Pro 
1               


<210> 1180
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1180
Ala Arg Gly Pro Val Gly Lys 
1               5           


<210> 1181
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1181
Pro Val Gly Lys 
1               


<210> 1182
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1182
Ala Arg Gly Pro Val Gly Lys Arg Leu Gln 
1               5                   10  


<210> 1183
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1183
Pro Val Gly Lys Arg Leu Gln 
1               5           


<210> 1184
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1184
Ala Arg Gly Pro Val Gly Lys Arg Leu Gln Gln 
1               5                   10      


<210> 1185
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1185
Pro Val Gly Lys Arg Leu Gln Gln 
1               5               


<210> 1186
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1186
Ala Arg Gly Pro Val Gly 
1               5       


<210> 1187
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1187
Gly Lys Arg Leu Gln Gln 
1               5       


<210> 1188
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1188
Val Gly Lys Arg Leu Gln 
1               5       


<210> 1189
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1189
Arg Leu Gln Gln Glu Leu 
1               5       


<210> 1190
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1190
Leu Met Thr Leu Met Met Ser 
1               5           


<210> 1191
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1191
Leu Met Met Ser 
1               


<210> 1192
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1192
Glu Leu Met Thr Leu Met Met Ser 
1               5               


<210> 1193
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1193
Gly Ala Val Ser Gly Ser Val Gln Ala Ser Asp 
1               5                   10      


<210> 1194
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1194
Met Ala Ser Met Gln Lys 
1               5       


<210> 1195
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1195
Ser Met Gln Lys 
1               


<210> 1196
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1196
Met Ala Ser Met Gln Lys Arg Leu Gln 
1               5                   


<210> 1197
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1197
Ser Met Gln Lys Arg Leu Gln 
1               5           


<210> 1198
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1198
Met Ala Ser Met Gln Lys Arg Leu Gln Lys 
1               5                   10  


<210> 1199
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1199
Ser Met Gln Lys Arg Leu Gln Lys 
1               5               


<210> 1200
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1200
Met Ala Ser Met Gln 
1               5   


<210> 1201
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1201
Gln Lys Arg Leu Gln Lys 
1               5       


<210> 1202
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1202
Met Gln Lys Arg Leu Gln 
1               5       


<210> 1203
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1203
Arg Leu Gln Lys Glu Leu Leu 
1               5           


<210> 1204
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1204
Leu Leu Ala Leu Gln Asn Asp 
1               5           


<210> 1205
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1205
Leu Gln Asn Asp 
1               


<210> 1206
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1206
Glu Leu Leu Ala Leu Gln Asn Asp 
1               5               


<210> 1207
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1207
Ala Leu Gln Asn Asp 
1               5   


<210> 1208
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1208
Ala Lys Lys Phe Phe Ser 
1               5       


<210> 1209
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1209
Lys Phe Phe Ser 
1               


<210> 1210
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1210
Ala Lys Lys Phe Phe Ser Thr Val Arg 
1               5                   


<210> 1211
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1211
Lys Phe Phe Ser Thr Val Arg 
1               5           


<210> 1212
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1212
Ala Lys Lys Phe Phe Ser Thr Val Arg Lys 
1               5                   10  


<210> 1213
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1213
Lys Phe Phe Ser Thr Val Arg Lys 
1               5               


<210> 1214
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1214
Ala Lys Lys Phe Phe 
1               5   


<210> 1215
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1215
Phe Ser Thr Val Arg Lys 
1               5       


<210> 1216
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1216
Phe Phe Ser Thr Val Arg 
1               5       


<210> 1217
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1217
Thr Val Arg Lys Glu Met Ala 
1               5           


<210> 1218
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1218
Met Ala Leu Leu Ala Thr Ser 
1               5           


<210> 1219
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1219
Leu Ala Thr Ser 
1               


<210> 1220
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1220
Glu Met Ala Leu Leu Ala Thr Ser 
1               5               


<210> 1221
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1221
Leu Leu Ala Thr Ser 
1               5   


<210> 1222
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1222
Ala Asn Asp Ala Asn Ser Ala Ala 
1               5               


<210> 1223
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1223
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg 
1               5                   10      


<210> 1224
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1224
Ala Arg Ala Arg 
1               


<210> 1225
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1225
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Ala 
1               5                   10                  


<210> 1226
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1226
Ala Arg Ala Arg Arg Leu Ala 
1               5           


<210> 1227
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1227
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala Arg Arg Leu Ala Gln 
1               5                   10                  15  


<210> 1228
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1228
Ala Arg Ala Arg Arg Leu Ala Gln 
1               5               


<210> 1229
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1229
Ala Asn Asp Ala Asn Ser Ala 
1               5           


<210> 1230
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1230
Ala Asn Asp Ala Asn Ser Ala Ala Arg Ala 
1               5                   10  


<210> 1231
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1231
Ala Arg Arg Leu Ala Gln 
1               5       


<210> 1232
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1232
Arg Ala Arg Arg Leu Ala 
1               5       


<210> 1233
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1233
Arg Leu Ala Gln Glu Ala 
1               5       


<210> 1234
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1234
Ala Val Thr Leu Ser Thr Ser 
1               5           


<210> 1235
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1235
Leu Ser Thr Ser 
1               


<210> 1236
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1236
Glu Ala Val Thr Leu Ser Thr Ser 
1               5               


<210> 1237
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1237
Thr Leu Ser Thr Ser 
1               5   


<210> 1238
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1238
Met Ala Ala Ser Arg 
1               5   


<210> 1239
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1239
Ala Ala Ser Arg 
1               


<210> 1240
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1240
Met Ala Ala Ser Arg Arg Leu Met 
1               5               


<210> 1241
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1241
Ala Ala Ser Arg Arg Leu Met 
1               5           


<210> 1242
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1242
Met Ala Ala Ser Arg Arg Leu Met Lys 
1               5                   


<210> 1243
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1243
Ala Ala Ser Arg Arg Leu Met Lys 
1               5               


<210> 1244
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1244
Met Ala Ala Ser 
1               


<210> 1245
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1245
Ser Arg Arg Leu Met Lys 
1               5       


<210> 1246
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1246
Ala Ser Arg Arg Leu Met 
1               5       


<210> 1247
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1247
Arg Leu Met Lys Glu Leu 
1               5       


<210> 1248
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1248
Leu Glu Glu Ile Arg Lys Cys 
1               5           


<210> 1249
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1249
Ile Arg Lys Cys 
1               


<210> 1250
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1250
Glu Leu Glu Glu Ile Arg Lys Cys 
1               5               


<210> 1251
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1251
Glu Ile Arg Lys Cys 
1               5   


<210> 1252
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1252
Met Met Ala Ser Met 
1               5   


<210> 1253
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1253
Met Ala Ser Met 
1               


<210> 1254
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1254
Met Met Ala Ser Met Arg Val Val 
1               5               


<210> 1255
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1255
Met Ala Ser Met Arg Val Val 
1               5           


<210> 1256
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1256
Met Met Ala Ser Met Arg Val Val Lys 
1               5                   


<210> 1257
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1257
Met Ala Ser Met Arg Val Val Lys 
1               5               


<210> 1258
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1258
Met Met Ala Ser 
1               


<210> 1259
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1259
Ser Met Arg Val Val Lys 
1               5       


<210> 1260
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1260
Ala Ser Met Arg Val Val 
1               5       


<210> 1261
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1261
Arg Val Val Lys Glu Leu 
1               5       


<210> 1262
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1262
Leu Glu Asp Leu Gln Lys Lys 
1               5           


<210> 1263
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1263
Leu Gln Lys Lys 
1               


<210> 1264
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1264
Glu Leu Glu Asp Leu Gln Lys Lys 
1               5               


<210> 1265
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1265
Asp Leu Gln Lys Lys 
1               5   


<210> 1266
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1266
Gly Pro Phe Tyr 
1               


<210> 1267
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1267
Gly Pro Phe Tyr Leu Glu Tyr 
1               5           


<210> 1268
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1268
Tyr Leu Glu Tyr 
1               


<210> 1269
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1269
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Leu 
1               5                   10  


<210> 1270
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1270
Tyr Leu Glu Tyr Ser Leu Leu 
1               5           


<210> 1271
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1271
Gly Pro Phe Tyr Leu Glu Tyr Ser Leu Leu Ala 
1               5                   10      


<210> 1272
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1272
Tyr Leu Glu Tyr Ser Leu Leu Ala 
1               5               


<210> 1273
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1273
Gly Pro Phe Tyr Leu Glu 
1               5       


<210> 1274
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1274
Glu Tyr Ser Leu Leu Ala 
1               5       


<210> 1275
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1275
Leu Glu Tyr Ser Leu Leu 
1               5       


<210> 1276
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1276
Ser Leu Leu Ala Glu Phe 
1               5       


<210> 1277
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1277
Phe Thr Leu Val Val Lys Gln 
1               5           


<210> 1278
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1278
Val Val Lys Gln 
1               


<210> 1279
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1279
Glu Phe Thr Leu Val Val Lys Gln 
1               5               


<210> 1280
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1280
Leu Val Val Lys Gln 
1               5   


<210> 1281
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1281
Gly Ala Val Ser Gly Ser Val Gln 
1               5               


<210> 1282
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1282
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp 
1               5                   10      


<210> 1283
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1283
Gln Ala Thr Asp 
1               


<210> 1284
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1284
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Met 
1               5                   10                  


<210> 1285
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1285
Gln Ala Thr Asp Arg Leu Met 
1               5           


<210> 1286
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1286
Gly Ala Val Ser Gly Ser Val Gln Ala Thr Asp Arg Leu Met Lys 
1               5                   10                  15  


<210> 1287
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1287
His Arg Asp Phe Cys Asp 
1               5       


<210> 1288
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1288
Gly Ala Val Ser Gly Ser Val 
1               5           


<210> 1289
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1289
Leu Met Lys Glu Ala Ala 
1               5       


<210> 1290
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1290
Leu Lys Gln Asp Tyr Leu 
1               5       


<210> 1291
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1291
Thr Asp Arg Leu Met Lys 
1               5       


<210> 1292
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1292
Ile Ile Lys Glu Thr Gln 
1               5       


<210> 1293
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1293
Leu Lys Arg Glu Leu His 
1               5       


<210> 1294
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1294
Leu Arg Asp Ile Tyr Arg Ser 
1               5           


<210> 1295
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1295
Ile Tyr Arg Ser 
1               


<210> 1296
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1296
Glu Leu Arg Asp Ile Tyr Arg Ser 
1               5               


<210> 1297
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1297
Asp Ile Tyr Arg Ser 
1               5   


<210> 1298
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1298
Leu Leu Glu Glu Leu Glu 
1               5       


<210> 1299
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1299
Val Tyr Lys Glu Val Thr 
1               5       


<210> 1300
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1300
Leu Gln Gln Glu Leu Met 
1               5       


<210> 1301
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1301
Leu Gln Lys Glu Leu Leu 
1               5       


<210> 1302
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1302
Val Arg Lys Glu Met Ala 
1               5       


<210> 1303
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1303
Leu Ala Gln Glu Ala Val 
1               5       


<210> 1304
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1304
Leu Met Lys Glu Leu Glu 
1               5       


<210> 1305
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1305
Gly Gln Ala Thr 
1               


<210> 1306
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1306
Val Val Lys Glu Leu Glu 
1               5       


<210> 1307
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1307
Leu Leu Ala Glu Phe Thr 
1               5       


<210> 1308
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1308
Leu Met Lys Glu Leu Arg 
1               5       


<210> 1309
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1309
Gly Ala Val Ser Gly Ser Val Gln Ala Thr 
1               5                   10  


<210> 1310
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1310
Asp Ile Tyr Arg Ser 
1               5   


<210> 1311
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1311
Glu Leu Arg Asp Ile Tyr Arg Ser 
1               5               


<210> 1312
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1312
Ala Thr Asp Arg Leu Met 
1               5       


<210> 1313
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1313
Gly Ala Val Ser Gly Ser Val 
1               5           


<210> 1314
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1314
Gln Ala Thr Asp Arg Leu Met Lys 
1               5               


<210> 1315
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1315
Thr Ser Ala Lys 
1               


<210> 1316
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1316
Ile Thr Leu Asp 
1               


<210> 1317
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1317
Thr Ser Ala Lys 
1               


<210> 1318
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1318
Ile Thr Leu Asp 
1               


<210> 1319
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1319
Thr Leu Met Met Ser 
1               5   


<210> 1320
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1320
Ser Asp Arg Leu Met Lys 
1               5       


<210> 1321
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1321
Met Ser Thr Pro Ala Arg Arg Arg Leu Met Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1322
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1322
Ala Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1323
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1323
Xaa Ala Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1324
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1324
Xaa Ser Ala Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1325
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1325
Xaa Ser Thr Ala Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1326
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1326
Xaa Ser Thr Pro Xaa Ala Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1327
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1327
Xaa Ser Thr Pro Xaa Arg Ala Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1328
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1328
Xaa Ser Thr Pro Xaa Arg Arg Ala Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1329
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1329
Xaa Ser Thr Pro Xaa Arg Arg Arg Ala Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1330
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1330
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Ala Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1331
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1331
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Ala Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1332
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1332
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Ala Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1333
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1333
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Ala Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1334
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1334
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Ala Leu 
1               5                   10                  15      


Gln 
    


<210> 1335
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1335
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Ala 
1               5                   10                  15      


Gln 
    


<210> 1336
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1336
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Ala 
    


<210> 1337
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1337
Xaa Ser Thr Pro Xaa Glu Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1338
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1338
Xaa Ser Thr Pro Xaa Arg Glu Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1339
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> R-octenyl alanine 

<400> 1339
Xaa Ser Thr Pro Xaa Arg Arg Glu Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1340
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Biotinylated Lysine 

<400> 1340
Xaa Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln Xaa 
            


<210> 1341
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<400> 1341
Xaa Pro Ser Ser Ala Ser Arg Gln Leu Leu Arg Lys Gln Leu Lys Glu 
1               5                   10                  15      


Ile Gln 
        


<210> 1342
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Biotinylated Lysine 

<400> 1342
Xaa Ser Thr Pro Ala Arg Arg Arg Leu Xaa Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln Xaa 
        


<210> 1343
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<400> 1343
Xaa Ser Thr Pro Ala Arg Arg Arg Leu Xaa Arg Asp Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1344
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> S-pentenyl alanine 

<400> 1344
Xaa Pro Ser Ser Ala Xaa Arg Gln Leu Leu Arg Lys Xaa Leu Lys Glu 
1               5                   10                  15      


Ile Gln Lys 
            


<210> 1345
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> S-pentenyl alanine 

<400> 1345
Xaa Xaa Leu Lys Arg Ile His Lys Xaa Leu Asn Asp Leu Ala Arg Asp 
1               5                   10                  15      


Lys 
    


<210> 1346
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1346
Xaa Ala Gly Thr Xaa Leu Lys Arg Leu Xaa Ala Xaa Tyr Lys Lys 
1               5                   10                  15  


<210> 1347
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1347
Xaa Ser Thr Pro Xaa Ala Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1348
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1348
Xaa Ser Thr Pro Xaa Arg Ala Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1349
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1349
Xaa Ser Thr Pro Xaa Arg Arg Ala Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1350
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1350
Xaa Ser Thr Pro Xaa Glu Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1351
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1351
Xaa Ser Thr Pro Xaa Arg Glu Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1352
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1352
Xaa Ser Thr Pro Xaa Arg Arg Glu Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1353
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1353
Xaa Ser Thr Pro Xaa Arg Ala Arg Ala Ala Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1354
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1354
Xaa Ser Thr Pro Xaa Arg Ala Arg Ala Ala Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1355
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1355
Xaa Ser Thr Pro Xaa Arg Arg Glu Leu Xaa Glu Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1356
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1356
Xaa Ser Thr Ala Xaa Glu Arg Glu Leu Xaa Glu Xaa Phe Ala Ala Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1357
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1357
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Cys Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1358
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1358
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Cys Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Lys 
        


<210> 1359
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Diamino butanoic acid terminating in bromoacetyl 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<400> 1359
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1360
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Diamino butanoic acid terminating in bromoacetyl 

<400> 1360
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Xaa Arg Leu 
1               5                   10                  15      


Gln 
    


<210> 1361
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Non-natural benzophenone-containing amino acid 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Biotinylated Lysine 

<400> 1361
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Xaa 
1               5                   10                  15      


Gln Xaa 
        


<210> 1362
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural benzophenone-containing amino acid 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Biotinylated Lysine 

<400> 1362
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Xaa Ala Ala Leu 
1               5                   10                  15      


Gln Xaa 
        


<210> 1363
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Non-natural benzophenone-containing amino acid 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Biotinylated Lysine 

<400> 1363
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Xaa 
        


<210> 1364
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Non-natural benzophenone-containing amino acid 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Biotinylated Lysine 

<400> 1364
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Phe Lys Arg Leu 
1               5                   10                  15      


Gln Xaa 
        


<210> 1365
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> R-octenyl alanine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Norleucine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> S-pentenyl alanine 

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Non-natural benzophenone-containing amino acid 

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Biotinylated Lysine 

<400> 1365
Xaa Ser Thr Pro Xaa Arg Arg Arg Leu Xaa Arg Xaa Xaa Lys Arg Leu 
1               5                   10                  15      


Gln Xaa 
        


